Standard Article

You have free access to this content

Mutagenesis

Genetic Toxicology, Oncogenesis, Developmental and Reproductive Toxicology

  1. Anthony Lynch

Published Online: 15 DEC 2009

DOI: 10.1002/9780470744307.gat074

General, Applied and Systems Toxicology

General, Applied and Systems Toxicology

How to Cite

Lynch, A. 2009. Mutagenesis. General, Applied and Systems Toxicology. .

Author Information

  1. Head, Investigative Genetic Toxicology, GalxoSmithKlyne Research and Development, Ware, Herefordshire, UK

Publication History

  1. Published Online: 15 DEC 2009

References

  1. References
  2. Further Reading
  • Aardema, M. J., Albertini, S., Arni, P., Henderson, L. M., Kirsh-Volders, M., Mackay, J. M., Sarrif, A. M., Stringer, D. A. and Taalman, R. D. F. (1998). Aneuploidy: a report of an ECETOC task force. Mutation Research, 410, 379.
  • Aardema, M. J., Snyder, R. D., Spicer, C., Divi, K., Morita, T., Mauthe, R. J., Gibson, D. P., Soelter, S., Curry, P. T., Thybaud, V., Lorenzon, G., Marzin, D. and Lorge, E. (2006). SFTG International collaborative study on the in vitro micronucleus test. III. Using CHO cells. Mutation Research, 607, 6187.
  • Abramsson-Zetterberg, L., Zetterberg, G., Bergqvist, M. and Grawé, J. (2000). Human cytogenetic biomonitoring using flow-cytometric analysis of micronuclei in transferrin-positive immature peripheral blood erythrocytes. Environmental and Molecular Mutagenesis, 36, 2231.
  • Abramsson-Zetterberg, L., Durling, L. J., Yang-Wallentin, F., Rytter, E. and Vessby, B. (2006). The impact of folate status and folic acid supplementation on the micronucleus frequency in human erythrocytes. Mutation Research, 603, 3340.
  • Alam, J. and Cook, J. L. (1990). Reporter genes: application to the study of mammalian gene transcription. Analytical Biochemistry, 188, 245254.
  • Alam, J. and Cook, J. L. (2003). Reporter genes for monitoring gene expression in mammalian cells. In Makrides, S. C. (Ed.), Gene Transfer and Expression in Mammalian Cells. Elsevier Science, Amsterdam, pp. 290308.
  • Amacher, D. E. and Turner, G. E. (1982). The effect of liver post-mitochondrial fraction concentration from Aroclor 1254-treated rats on promutagen activation in L5178Y cells. Mutation Research, 97, 131137.
  • Ames, B. N. (1971). The detection of chemical mutagens with enteric bacteria. In Hollaender, A. (Ed.), Chemical Mutagens, Principles and Methods for their Detection, Vol. 1, Plenum Press, New York, pp. 267282.
  • Ames, B. N., Durston, W. E., Yamasaki, E. and Lee, F. D. (1973). Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proceedings of the National Academy of Sciences, 70, 22812285.
  • Ames, B. N., McCann, J. and Yamasaki, E. (1975). Methods for detecting carcinogens and mutagens with the salmonella/mammalian microsome mutagenicity test. Mutation Research, 31, 347364.
  • An, G., Hidaka, K. and Siminovitch, L. (1982). Expression of bacterial b-galactosidase in animal cells. Molecular and Cellular Biology, 2, 16281632.
  • Andersson, H. C. (1993). The spontaneous frequency of chromosomal aberrations and sister-chromatid exchanges in cultured peripheral lymphocytes of a single blood donor sampled more than 200 times. Mutation Research, 286, 281292.
  • Applegate, M. L., Moore, M. M., Broder, C. B., Burrell, A., Juhn, G., Kasweck, K. L., Lin, P. F., Wadhams, A. and Hozier, J. C. (1990). Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proceedings of the National Academy of Sciences, 87, 5155.
  • Armstrong, M. J., Bean, C. L. and Galloway, S. M. (1992). A quantitative assessment of the cytotoxicity associated with chromosomal aberration detection in Chinese hamster ovary cells. Mutation Research, 265, 4560.
  • Armstrong, M. J., Gara, J. P., Gealy, R. III, Greenwood, S. K., Hilliard, C. A., Laws, G. M. and Galloway, S. M. (2000). Induction of chromosome aberrations in vitro by phenolphthalein: mechanistic studies. Mutation Research, 457, 1530.
  • Ashby, J. (1997). Cell transformation assays as predictors of carcinogenic potential. Toxicologic Pathology, 25, 334335.
  • Ashby, J. and Tennant, R. W. (1991). Definitive relationships among chemical structure, carcinogenicity, and mutagenicity for 301 chemicals tested by the US NTP. Mutation Research, 257, 229306. Erratum in: Mutation Research (1994), 317, 175.
  • Auerbach, C. and Robson, J. M. (1944). Production of mutations by allyl isothiocyanate. Nature, 154, 8182.
  • Auerbach, C. and Robson, J. M. (1946). Chemical production of mutations. Nature, 157, 302.
  • Austin, M. A., Hutter, C. M., Zimmern, R. L. and Humphries, S. E. (2004). Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. American Journal of Epidemiology, 160, 407420.
  • Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. and Vogelstein, B. (1990). Suppression of human colorectal carcinoma cell growth by wild-type p53. Science, 249, 912915.
  • Balaban, R. S., Shino, N. and Toren, F. (2005). Mitochondria, oxidants, and aging this issue, Cell, 120, 483495.
  • Barja, G. (2004). Free radicals and aging. Trends in Neurosciences, 27, 595600.
  • Bateman, A. J. (1966). Testing chemicals for mutagenicity in a mammal. Nature, 210, 205206.
  • Benigni, R. and Richard, A. M. (1996). QSAR's of mutagens and carcinogens: two case studies illustrating problems in the construction of models for non-congeneric chemicals. Mutation Research, 371, 2946.
  • Ben-Porath, I. and Weinberg, R. A. (2004). When cells get stressed: an integrative view of cellular senescence. The Journal of Clinical Investigation, 113, 813.
  • Ben-Porath, I. and Weinberg, R. A. (2005). The signals and pathways activating cellular senescence. The International Journal of Biochemistry and Cell Biology, 37, 961976.
  • Bentley, K. S., Kirkland, D., Murphy, M. and Marshall, R. (2000). Evaluation of thresholds for benomyl- and carbendazim-induced aneuploidy in cultured human lymphocytes using fluorescence in situ hybridization. Mutation Research, 464, 4151.
  • Beroud, C., Collod-Beroud, G., Boileau, C., Soussi, T. and Junien, C. (2000). UMD (Universal mutation database): a generic software to build and analyze locus-specific databases. Human Mutation, 15, 8694.
  • Besson, A., Dowdy, S. F. and Roberts, J. M. (2008). CDK inhibitors: cell cycle regulators and beyond. Developmental Cell, 14, 159169.
  • Bigger, A. (2003). CDER Position on the Use of the SHE Cell Transformation Assay in Regulatory Determinations. Regulatory and Safety Evaluation Speciality Section—Newsletter of the Society of Toxicology, Summer 2003. www.toxicology.org/ISOT/SS/regulatorysafety/NLSummer_2003.pdf
  • Billinton, N., Hastwell, P. W., Beerens, D., Birrell, L., Ellis, P., Maskell, S., Webster, T. W., Windebank, S., Woestenborghs, F., Lynch, A. M., Scott, A. D., Tweats, D. J., van Gompel, J., Rees, R. W. and Walmsley, R. M. (2008). Interlaboratory assessment of the GreenScreen HC GADD45a-GFP genotoxicity screening assay: an enabling study for independent validation as an alternative method. Mutation Research, 653, 2333.
  • Bishop, J. B., Witt, K. L. and Sloane, R. A. (1997). Genetic toxicities of human teratogens. Mutation Research, 396, 943.
  • Blakey, D. H., Douglas, G. R., Huang, K. C. and Winter, H. J. (1995). Cytogenetic mapping of lambda gt10 lacZ sequences in the transgenic mouse strain 40.6 (Muta Mouse). Mutagenesis, 10, 145148.
  • Bocchetta, M. and Carbone, M. (2004). Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformation. Oncogene, 38, 64846491.
  • Boerrigter, M. E., Dolle, M. E., Martus, H. J., Gossen, J. A. and Vijg, J. (1995). Plasmid-based transgenic mouse model for studying in vivo mutations. Nature, 377, 657659.
  • Boice, J. D. Jr., Tawn, E. J., Winther, J. F., Donaldson, S. S., Green, D. M., Mertens, A. C., Mulvihill, J. J., Olsen, J. H., Robison, L. L. and Stovall, M. (2003). Genetic effects of radiotherapy for childhood cancer. Health Physics, 85, 6580.
  • Bolt, H. M. and Degen, G. H. (2004). Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis. Toxicological Sciences, 81, 36.
  • Bonacker, D., Stoiber, T., Böhm, K. J., Unger, E., Degen, G. H., Thier, R. and Bolt, H. M. (2004). Chromosomal genotoxicity of nitrobenzene and benzonitrile. Archives of Toxicology, 78, 4957.
  • Bos, P. M., Baars, P. J. and Raaij, M. T. (2004). Risk assessment of peak exposure to genotoxic carcinogens: a pragmatic approach. Toxicology Letters, 151, 4350.
  • Bottoni, A., Zatelli, M. C., Ferracin, M., Tagliati, F., Piccin, D., Vignali, C., Calin, G. A., Negrini, M., Croce, C. M. and DegliUberti, E. C. (2007). Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. Journal of Cellular Physiology, 2, 370377.
  • Bouffler, S. D., Bridges, B. A., Cooper, D. N., Dubrova, Y., McMillan, T. J., Thacker, J., Wright, E. G. and Waters, R. (2006). Assessing radiation-associated mutational risk to the germline: repetitive DNA sequences as mutational targets and biomarkers. Radiation Research, 165, 249268.
  • Branzei, D. and Foiani, M. (2008). Regulation of DNA repair throughout the cell cycle. Nature Reviews: Molecular Cell Biology, 9, 297308.
  • Brendler-Schwaab, S., Czich, A., Epe, B., Gocke, E., Kaina, B., Müller, L., Pollet, D. and Utesch, D. (2004). Photochemical genotoxicity: principles and test methods. Report of a GUM task force. Mutation Research, 566, 6591.
  • Bridges, B. A., Dennis, R. E. and Munson, R. J. (1967). Differential induction and repair of ultraviolet damage leading to true reversions and external suppressor mutations of an ochre codon in Escherichia coli B-r WP2. Genetics, 57, 897908.
  • Bromfield, C. E. (2009). Investigation into cytotoxicity endpoints used in the in vitro mammalian genotoxicity assays. Mutagenesis, 24, 107.
  • Brosh, R. M. Jr. and Bohr, V. A. (2007). Human premature aging, DNA repair and RecQ helicases. Nucleic Acids Research, 35, 75277544.
  • Brusick, D. (1986). Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations. Environmental Mutagenesis, 8, 879886.
  • Bryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A. and Reddel, R. R. (1997). Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Medicine, 11, 12711274.
  • Bryce, S. M., Avlasevich, S. L., Bemis, J. C., Lukamowicz, M., Elhajouji, A., Van Goethem, F., De Boeck, M., Beerens, D., Aerts, H., Van Gompel, J., Collins, J. E., Ellis, P. C., White, A. T., Lynch, A. M. and Dertinger, S. D. (2008). Interlaboratory evaluation of a flow cytometric, high content in vitro micronucleus assay. Mutation Research, 650, 181195.
  • Bullock, C. and Gorman, C. (2000). Fusions to chloramphenicol acetyltransferase as a reporter. Methods in Enzymology, 326, 202221.
  • Burlinson, B., Tice, R. R., Speit, G., Agurell, E., Brendler-Schwaab, S., Collins, A., Escobar, P., Honma, M., Kumaravel, T., Nakajima, M., Sasaki, Y. F., Thybaud, V., Uno, Y., Vasquez, M. and Hartmann, A. (2007). Fourth international workgroup on genotoxicity testing: results of the in-vivo comet assay workgroup. Mutation Research, 627, 3135.
  • Butterworth, B. E., Ashby, J., Bermudez, E., Casciano, D., Mirsalis, J., Probst, G. and Williams, G. M. (1987). A protocol and guide for the in vivo rat hepatocyte DNA-repair assay. Mutation Research, 189, 123133.
  • Cahill, P. A., Knight, A. W., Billinton, N., Barker, M. G., Walsh, L., Keenan, P. O., Williams, C. V., Tweats, D. J. and Walmsley, R. M. (2004). The GreenScreen® genotoxicity assay: a screening validation programme. Mutagenesis, 19, 105119.
  • Calman, K. C. (1996). Cancer: science and society and the communication of risk. British Medical Journal, 313, 799802.
  • Carter, T. C., Lyon, M. F. and Phillips, R. J. S. (1956). Induction of mutations in mice by chronic gamma irradiation: interim report. The British Journal of Radiology, 29, 106108.
  • Cheadle, J. P. and Sampson, J. R. (2007). MUTYH-associated polyposis from defect in base excision repair to clinical genetic testing. DNA Repair (Amsterdam), 6, 274279.
  • Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S. L., Gottlieb, G. J., Greider, C. W. and DePinho, R. A. (1999). p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell, 4, 527538.
  • Cho, K. R. and Vogelstein, B. (1992). Genetic alterations in the adenoma–carcinoma sequence. Cancer, 70 (Suppl 6), 17271731.
  • Chumakov, P. M. (2007). Versatile functions of p53 protein in multicellular organisms. Biochemistry (Moscow), 72, 13991421.
  • Ciafre, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C. G., Sabatino, G., Negrini, M., Maira, G., Croce, C. M. and Farace, M. G. (2005). Extensive modulation of a set of microRNAs in primary glioblastoma. Biochemical and Biophysical Research Communications, 4, 13511358.
  • Clare, G., Lorenzon, G., Akhurst, L. C., Marzin, D., van Delft, J., Montero, R., Botta, A., Bertens, A., Cinelli, S., Thybaud, V. and Lorge, E. (2006). SFTG International collaborative study on the in vitro micronucleus test. II. Using human lymphocytes. Mutation Research, 607, 3760.
  • Cleaver, J. E. and Crowley, E. (2002). UV damage, DNA repair and skin carcinogenesis. Frontiers in Bioscience, 7, 10241043.
  • Clive, D., Bolcsfoldi, G., Clements, J., Cole, J., Homna, M., Majeska, J., Moore, M., Müller, L., Myhr, B., Oberly, T., Oudelhkim, M.-C., Rudd, C., Shimada, H., Sofuni, T., Thybaud, V. and Wilcox, P. (1995). Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop. Environmental and Molecular Mutagenesis, 25, 165168.
  • Clive, D., Johnson, K. O., Spector, J. F. S., Batson, A. G. and Brown, M. M. (1979). Validation and characterisation of the L5178Y/TK+/− mouse lymphoma mutagen assay system. Mutation Research, 59, 61108.
  • Cole, J. and Arlett, C. F. (1984). The detection of gene mutations in cultured mammalian cells. In Venitt, S. and Parry, J. M. (Eds), Mutagenicity Testing—a Practical Approach. IRL Press, Oxford, pp. 233273.
  • Cole, J., Fox, M., Garner, R. C., Mcgregor, D. B. and Thacker, J. (1990). Gene mutation assays in cultured mammalian cells. In Kirkland, D. J. (Ed.), Basic Mutagenicity Tests: UKEMS Recommended Procedures. Cambridge University Press, Cambridge, pp. 87114.
  • Collins, A. R. (2004). Comet assay for DNA damage and repair: principles, applications and limitations. Molecular Biotechnology, 26, 249261.
  • Collins, A. R., Dusinská, M. and Horská, A. (2001). Detection of alkylation damage in human lymphocyte DNA with the comet assay. Acta Biochimica Polonica, 48, 611614.
  • Collins, J. E., Ellis, P. C., White, A. T., Booth, A. E., Moore, C. E., Burman, M., Rees, R. W. and Lynch, A. M. (2008a). Evaluation of the Litron In Vitro MicroFlow Kit for the flow cytometric enumeration of micronuclei (MN) in mammalian cells. Mutation Research, 654, 7681.
  • Collins, A. R., Oscoz, A. A., Brunborg, G., Gaivão, I., Giovannelli, L., Kruszewski, M., Smith, C. C. and Stetina, R. (2008b). The comet assay: topical issues. Mutagenesis, 23, 143151.
  • COM (2000). Guidance on a Strategy for Testing of Chemicals for Mutagenicity. UK Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment, December 2000. Department of Health, London. www.iacom.org.uk/publications/documents/guidance.pdf.
  • Comma, L. (1977). Ministerial Decrees. The testing of pharmaceutical products prior to clinical trials. Gazzetta Ufficiale, 216, (August 1977); 238, (September 1977), Rome.
  • Cormier, R. T., Hong, K. H., Halberg, R. B., Hawkins, T. L., Richardson, P., Mulherkar, R., Dove, W. F. and Lander, E. S. (1997). Secretory phospholipase Pla2 g2a confers resistance to intestinal tumorigenesis. Nature Genetics, 17, 8891.
  • Corvi, R., Albertini, S., Hartung, T., Hoffmann, S., Maurici, D., Pfuhler, S., van Benthem, J. and Vanparys, P. (2008). ECVAM retrospective validation of in vitro micronucleus test (MNT). Mutagenesis, 23, 271283.
  • Countryman, P. I. and Heddle, J. A. (1976). The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutation Research, 41, 321332.
  • Crow, J. F. (1989). Concern for environmental mutagens: some personal reminiscences. Environmental and Molecular Mutagenesis, 14 (Suppl 16), 710.
  • Crum-Brown, A. and Frazer, T. (1868). On connection between chemical constitution and physiological action. Transactions of the Royal Society of Edinburgh, 25, 151203.
  • d'Adda di Fagagna, F., Teo, S. H. and Jackson, S. P. (2004). Functional links between telomeres and proteins of the DNA-damage response. Genes and Development, 18, 17811799.
  • Davies, A. M., Martin, E. A., Jones, R. M., Lim, C. K., Smith, L. L. and White, I. N. (1995). Peroxidase activation of tamoxifen and toremifene resulting in DNA damage and covalently bound protein adducts. Carcinogenesis, 16, 539545.
  • De La Rosa-Velázquez, I. A., Rincón-Arano, H., Benitez-Bribiesca, L. and Recillas-Targa, F. (2007). Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF. Cancer Research, 6, 25772585.
  • Dean, S. W. and Myhr, B. (1994). Measurement of gene mutations in vivo using Muta mouse and positive selection for lacZ- phage. Mutagenesis, 9, 183185.
  • Dearden, J. C. (2003). In silico prediction of drug toxicity. Journal of Computer-Aided Molecular Design, 17, 119127.
  • Dearfield, K. L. and Moore, M. M. (2005). Use of genetic toxicology information for risk assessment. Environmental and Molecular Mutagenesis, 46, 236245.
  • Decordier, I., Cundari, E. and Kirsch-Volders, M. (2008). Mitotic checkpoints and the maintenance of the chromosome karyotype. Mutation Research, 651, 313.
  • Decordier, I., Dillen, L., Cundari, E. and Kirsch-Volders, M. (2002). Elimination of micronucleated cells by apoptosis after treatment with inhibitors of microtubules. Mutagenesis, 17, 337344.
  • Dekker, M. C. and van Duijn, C. M. (2003). Prospects of genetic epidemiology in the 21st century. European Journal of Epidemiology, 18, 607616.
  • Delaney, E. J. (2007). An impact analysis of the application of the threshold of toxicological concern concept to pharmaceuticals. Regulatory Toxicology and Pharmacology, 49, 107124.
  • Delaney, J. C. and Essigmann, J. M. (2008). Biological properties of single chemical-DNA adducts: a twenty year perspective. Chemical Research in Toxicology, 21, 232252.
  • Dertinger, S. D., Torous, D. K., Hall, N. E., Tometsko, C. R. and Gasiewicz, T. A. (2000). Malaria-infected erythrocytes serve as biological standards to ensure reliable and consistent scoring of micronucleated erythrocytes by flow cytometry. Mutation Research, 464, 195200.
  • Dertinger, S. D., Chen, Y., Miller, R. K., Brewer, K. J., Smudzin, T., Torous, D. K., Hall, N. E., Olvany, K. A., Murante, F. G. and Tometsko, C. R. (2003). Micronucleated CD71-positive reticulocytes: a blood-based endpoint of cytogenetic damage in humans. Mutation Research, 542, 7787.
  • Dertinger, S. D., Camphausen, K., Macgregor, J. T., Bishop, M. E., Torous, D. K., Avlasevich, S., Cairns, S., Tometsko, C. R., Menard, C., Muanza, T., Chen, Y., Miller, R. K., Cederbrant, K., Sandelin, K., Ponten, I. and Bolcsfoldi, G. (2004). Three-color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood. Environmental and Molecular Mutagenesis, 44, 427435.
  • Dertinger, S. D., Miller, R. K., Brewer, K., Smudzin, T., Torous, D. K., Roberts, D. J., Avlasevich, S. L., Bryce, S. M., Sugunan, S. and Chen, Y. (2007). Automated human blood micronucleated reticulocyte measurements for rapid assessment of chromosomal damage. Mutation Research, 626, 111119.
  • DHSS (1981). Guidelines for the Testing of Chemicals for Mutagenicity. Prepared by the Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment, Department of Health and Social Security. Report on Health and Social Subjects, No. 24. Her Majesty's Stationary Office, London.
  • Diaz, D., Scott, A., Carmichael, P., Shi, W. and Costales, C. (2007). Evaluation of an automated in vitro micronucleus assay in CHO-K1 cells. Mutation Research, 630, 113.
  • Dietrich, W. F., Lander, E. S., Smith, J. S., Moser, A. R., Gould, K. A., Luongo, C., Borenstein, N. and Dove, W. F. (1993). Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell, 75, 631639.
  • Dihlmann, S., Gebert, J., Siermann, A., Herfarth, C. and von Knebel Doeberitz, M. (1999). Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis. Cancer Research, 59, 18571860.
  • Dixon, D. R., Pruski, A. M., Dixon, L. R. J. and Jha, A. N. (2002). Marine invertebrate eco-genotoxicology: a methodological overview. Mutagenesis, 17, 495507.
  • Doak, S. H., Jenkins, G. J., Johnson, G. E., Quick, E., Parry, E. M. and Parry, J. M. (2007). Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Research, 67, 39043911.
  • Doherty, A. T., Ellard, S., Parry, E. M. and Parry, J. M. (1996). A study of the aneugenic activity of trichlorfon detected by centromere-specific probes in human lymphoblastoid cell lines. Mutation Research, 372, 221231.
  • Doll, R. (1998). Epidemiological evidence of the effects of behaviour and the environment on the risk of human cancer. Recent Results in Cancer Research, 154, 321.
  • Dubrova, Y. E., Jeffreys, A. J. and Malashenko, A. M. (1993). Mouse minisatellite mutations induced by ionizing radiation. Nature Genetics, 5, 9294.
  • Dufour, E. K., Kumaravel, T., Gerhard, J., Nohynek, G. J., Kirkland, D. and Toutain, H. (2006). Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells. Mutation Research, 607, 215224.
  • Dunnick, J. K., Forbes, P. D., Eustis, S. L., Hardisty, J. F. and Goodman, D. G. (1991). Tumours of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation. Fundamental and Applied Toxicology, 16, 92102.
  • Dycaico, M. J., Provost, G. S., Kretz, P. L., Ransom, S. L., Moores, J. C. and Short, J. M. (1994). The use of shuttle vectors for mutation analysis in transgenic mice and rats. Mutation Research, 307, 461478.
  • Edler, L. and Kopp-Schneider, A. (1998). Statistical models for low dose exposure. Mutation Research, 402, 227236.
  • EEC (1984). Methods for the determination of physico-chemical properties, toxicity and ecotoxicity; Annex V to Directive 79/831/EEC. Official Journal of the European Communities, L251, 131145.
  • Elbirt, K. K. and Bonkovsky, H. L. (1999). Heme oxygenase: recent advances in understanding its regulation and role. Proceedings of the Association of American Physicians, 111, 438447.
  • Elespuru, R. K. and Sankaranarayanan, K. (2007). New approaches to assessing the effects of mutagenic agents on the integrity of the human genome. Mutation Research, 616, 8389.
  • Elhajouji, A., Tibaldi, F. and Kirsch-Volders, M. (1997). Indications for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in-vivo in human lymphocytes. Mutagenesis, 12, 133140.
  • Elhajouji, A., Van Hummelen, P. and Kirsch-Volders, M. (1995). Indications for a threshold of chemically induced aneuploidy in-vitro in human lymphocytes. Environmental and Molecular Mutagenesis, 26, 292304.
  • Elliot, B. M., Combes, R. D., Elcombe, C. R., Gatehouse, D. G., Gibson, G. G., Mackay, J. M. and Wolf, R. C. (1992). Report of UK Environmental Mutagen Society working party. Alternatives to Aroclor 1254-induced S9 in in vitro genotoxicity assays. Mutagenesis, 7, 175177.
  • EPA (1982). Health Effects Test Guidelines. Office of Toxic Substances, Environmental Protection Agency, Washington, DC.
  • Eriksson, M., Brown, W. T., Gordon, L. B., Glynn, M. W., Singer, J., Scott, L., Erdos, M. R., Robbins, C. M., Moses, T. Y., Berglund, P., Dutra, A., Pak, E., Durkin, S., Csoka, A. B., Boehnke, M., Glover, T. W. and Collins, F. S. (2003). Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature, 423, 293298.
  • Esteller, M. (2005). Aberrant DNA methylation as a cancer-inducing mechanism. Annual Review of Pharmacology and Toxicology, 45, 629656.
  • Esteller, M. (2006). The necessity of a human epigenome project. Carcinogenesis, 6, 11211125.
  • Esteller, M., Cordon-Cardo, C., Corn, P. G., Meltzer, S. J., Pohar, K. S., Watkins, D. N., Capella, G., Peinado, M. A., Matias-Guiu, X., Prat, J., Baylin, S. B. and Herman, J. G. (2001). p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2. Cancer Research, 7, 28162821.
  • Esteller, M., Sparks, A., Toyota, M., Sanchez-Cespedes, M., Capella, G., Peinado, M. A., Gonzalez, S., Tarafa, G., Sidransky, D., Meltzer, S. J., Baylin, S. B. and Herman, J. G. (2000). Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Research, 16, 43664371.
  • European Medicines Evaluation Agency (2006). Committee for Medicinal Products for Human Use (CHMP). Guideline on the Limits of Genotoxic Impurities. EMEA/CHMP/QWP/251344/2006. EMEA, London. www.emea.europa.eu/pdfs/human/swp/519902en.pdf.
  • European Medicines Evaluation Agency (2007). Revision 1. CHMP Safety Working Party (SWP). Question & Answers on the CHMP Guideline on the Limits of Genotoxic Impurities. EMEA/CHMP/SWP/431994/2007. EMEA, London. www.emea.europa.eu/pdfs/human/swp/43199407en.pdf.
  • Evans, H. J. (1976). Cytological methods for detecting chemical mutagens. In Hollaender, A. (Ed.), Chemical Mutagens, Principles and Methods for their Detection, Vol. 4, Plenum Press, New York, pp. 129.
  • Evans, D. G., Guy, S. P., Thakker, N., Armstrong, J. G., Dodd, C., Davies, D. R., Babbs, C., Clancy, T., Warnes, T. and Sloan, P. (1993). Non-penetrance and late appearance of polyps in families with familial adenomatous polyposis. Gut, 34, 13891393.
  • Evans, S. M., Hahn, S. M., Magarelli, D. P. and Koch, C. J. (2001). Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation. American Journal of Clinical Oncology, 5, 467472.
  • Fairbairn, D. W., Olive, P. L. and O'Neill, K. L. (1995). The comet assay: a comprehensive review. Mutation Research, 339, 3759.
  • Farmer, P. B. (2002). Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment ILSI/HESI research programme on alternative cancer models: results of Syrian hamster embryo cell transformation assay. Toxicologic Pathology, 30, 536538.
  • Farmer, P. B., Brown, K., Tompkins, E., Emms, V. L., Jones, D. J., Singh, R. and Phillips, D. H. (2005). DNA adducts: mass spectrometry methods and future prospects. Toxicology and Applied Pharmacology, 207 (2 Suppl), 293301.
  • Farmer, P. B. and Shuker, D. E. (1999). What is the significance of increases in background levels of carcinogen-derived protein and DNA adducts? Some considerations for incremental risk assessment. Mutation Research, 424, 275286.
  • FDA (Food and Drug Administration) CDER (Center for Drug Evaluation and Research) (2006). Guidance for Industry and Review Staff: Recommended Approaches to Integration of Genetic Toxicology Study Results, January 2006. CDER, Rockville, MD. www.fda.gov/Cder/guidance/6848fnl.pdf.
  • Feinberg, A. P., Cui, H. and Ohlsson, R. (2002). DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. Seminars in Cancer Biology, 5, 389398.
  • Fellows, M. D. and O'Donovan, M. R. (2007). Cytotoxicity in cultured mammalian cells is a function of the method used to estimate it. Mutagenesis, 22, 275280.
  • Fellows, M. D., O'Donovan, M. R., Lorge, E. and Kirkland, D. (2008). Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test. II. Practical aspects with toxic agents. Mutation Research, 655, 421.
  • Fenech, M. (2007). The cytokinesis-block micronucleus cytome assay. Nature Protocols, 2, 10841104.
  • Fenech, M. and Morley, A. A. (1986). Cytokinesis-block micronucleus method in human lymphocytes: effect of in-vivo ageing and low dose X-irradiation. Mutation Research, 161, 193198.
  • Ferguson, D. O. and Alt, F. W. (2001). DNA double strand break repair and chromosomal translocation: lessons from animal models. Oncogene, 20, 55725579.
  • Ferguson, L. R. and Denny, W. A. (2007). Genotoxicity of non-covalent interactions: DNA intercalators. Mutation Research, 623, 1423.
  • Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M. and Kemp, C. J. (1998). The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature, 396, 177180.
  • Field, L. L., McArthur, R. G., Shin, S. Y. and Yoon, J. W. (1987). The relationship between Coxsackie-B-virus-specific IgG responses and genetic factors (HLA-DR, GM, KM) in insulin-dependent diabetes mellitus. Diabetes Research, 6, 169173.
  • Fielder, R. J., Allen, J. A., Boobis, A. R., Botham, P. A., Doe, J., Esdaile, D. J., Gatehouse, D. G., Hodson-Walker, G., Morton, D. B., Kirkland, D. J. and Richold, M. (1993). Report of the BTS/UKEMS Working Group on dose setting in in vivo mutagenicity assays. Human and Experimental Toxicology, 12, 189198.
  • Fisher, A. E., Burke, D. and Routledge, M. N. (2007). Can irradiation of rectal tumour cells from patient biopsy predict outcome of radiotherapy? Proceedings of the Genome Stability Network/United Kingdom Environmental Mutagen Society Joint Congress, University of Cardiff, 1–4 July 2007.
  • Fleisher, A. S., Esteller, M., Wang, S., Tamura, G., Suzuki, H., Yin, J., Zou, T. T., Abraham, J. M., Kong, D., Smolinski, K. N., Shi, Y. Q., Rhyu, M. G., Powell, S. M., James, S. P., Wilson, K. T., Herman, J. G. and Meltzer, S. J. (1999). Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Research, 5, 10901095.
  • Flückiger-Isler, S. and Kamber, M. (2007). The Ames MPF® 98/100 assay: novel mutagenicity testing in liquid microplate format using S. typhimurium TA98, TA100, TA1535 and TA1537. Paper shown at the SOT 2007, Charlotte, USA.
  • Flume, P. A. and Stenbit, A. (2008). Making the diagnosis of cystic fibrosis. American Journal of the Medical Sciences, 335, 5154.
  • Fodde, R., Edelmann, W., Yang, K., van Leeuwen, C., Carlson, C., Renault, B., Breukel, C., Alt, E., Lipkin, M. and Khan, P. M. (1994). A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proceedings of the National Academy of Sciences, 91, 89698973.
  • Folkman, J. (1990). What is the evidence that tumors are angiogenesis dependent? Journal of the National Cancer Institute, 1, 46.
  • Folkman, J. (2002). The role of angiogenesis in tumor growth and metastasis. Seminars in Oncology, 29 (Suppl 16), 1518.
  • Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D. and Semenza, G. L. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology, 9, 46044613.
  • Fortune, J. M. and Osheroff, N. (2000). Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. Progress in Nucleic Acid Research and Molecular Biology, 64, 221523.
  • Fraga, M. F. and Esteller, M. (2005). Towards the human cancer epigenome: a first draft of histone modifications. Cell Cycle, 10, 13771381.
  • Fraga, M. F., Herranz, M., Espada, J., Ballestar, E., Paz, M. F., Ropero, S., Erkek, E., Bozdogan, O., Peinado, H., Niveleau, A., Mao, J. H., Balmain, A., Cano, A. and Esteller, M. (2004). A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Research, 16, 55275534.
  • Fukushima, T., Katayama, Y., Watanabe, T., Yoshino, A., Ogino, A., Ohta, T. and Komine, C. (2005). Promoter hypermethylation of mismatch repair gene hMLH1 predicts the clinical response of malignant astrocytomas to nitrosourea. Clinical Cancer Research, 4, 15391544.
  • Fung, Y. K. T., Murphree, A. L., T'Ang, A., Qian, J., Hinrichs, S. H. and Benedict, W. F. (1987). Structural evidence for the authenticity of the human retinoblastoma gene. Science, 236, 16571661.
  • Galloway, S. M. (2000). Cytotoxicity and chromosome aberrations in vitro: experience in industry and the case for an upper limit on toxicity in the aberration assay. Environmental and Molecular Mutagenesis, 35, 191201.
  • Galloway, S. M., Armstrong, M. J., Reuben, C., Colman, S., Brown, B., Cannon, C., Bloom, A. D., Nakamura, F., Ahmed, M., Duk, S., Rimpo, J., Margolin, G. H., Resnick, M. A., Anderson, G. and Zeiger, E. (1987). Chromosome aberration and sister chromatid exchanges in Chinese hamster ovary cells: evaluation of 108 chemicals. Environmental and Molecular Mutagenesis, 10 (Suppl 10), 1175.
  • Galloway, S. M., Greenwood, S. K., Hill, R. B., Sun, J. T., Armstrong, M. J., Johnson, T. E. and Gara, J. P. (2000). A simple method for more accurate calculation of cell growth for the in vitro chromosome aberration assay. Environmental and Molecular Mutagenesis, 35 (Suppl 31), 24.
  • Galloway, S. M., Miller, J. E., Armstrong, M. J., Bean, C. L., Skopek, T. R. and Nichols, W. W. (1998). DNA synthesis inhibition as an indirect mechanism of chromosome aberrations: comparison of DNA-reactive and non-DNA-reactive clastogens. Mutation Research, 400, 169186.
  • Gao, J. and Richardson, D. R. (2001). The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: The mechanisms involved in inhibiting cell-cycle progression. Blood, 98, 842850.
  • Garner, R. C., Miller, E. C. and Miller, J. A. (1972). Liver microsomal metabolism of aflatoxin B1 to a reactive derivative toxic to salmonella typhimurium TA 1530. Cancer Research, 32, 20582066.
  • Gatehouse, D. G., Wilcox, P., Forster, R., Rowland, I. R. and Callander, R. D. (1990). Bacterial mutation assays. In Kirkland, D. J. (Ed.), Basic Mutagenicity Tests: UKEMS Recommended Procedures. Cambridge University Press, Cambridge, pp. 1361.
  • Gee, P., Maron, D. M. and Ames, B. N. (1994). Detection and classification of mutagens: a set of base-specific Salmonella tester strains. Proceedings of the National Academy of Sciences, 91, 1160611610.
  • Gee, P., Sommers, C. H., Melick, A. S., Gidrol, X. M., Todd, M. D., Burris, R. B., Nelson, M. E., Klemm, R. C. and Zeiger, E. (1998). Comparison of responses of base-specific Salmonella tester strains with the traditional strains for identifying mutagens: the results of a validation study. Mutation Research, 412, 115130.
  • van Gent, D. C., Hoeijmakers, J. H. and Kanaar, R. (2001). Chromosomal stability and the DNA double-stranded break connection. Nature Reviews: Genetics, 2, 196206.
  • Gilbert, W. (1978). Why genes in pieces. Nature, 271, 501.
  • Gocke, E. (2001). Photochemical mutagenesis: examples and toxicological relevance. Journal of Environmental Pathology, Toxicology and Oncology, 20, 285292.
  • Gocke, E., Albertini, S., Chételat, A. A., Kirchner, S. and Muster, W. (1998). The photomutagenicity of fluoroquinolones and other drugs. Toxicology Letters, 102/103, 375381.
  • Gorman, C. M., Moffat, L. F. and Howard, B. H. (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Molecular and Cellular Biology, 2, 10441051.
  • Gossen, J. A., de Leeuw, W. J., Tan, C. H., Zwarthoff, E. C., Berends, F., Lohman, P. H., Knook, D. L. and Vijg, J. (1989). Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proceedings of the National Academy of Sciences of the United States of America, 86, 79717975.
  • Gossen, J. A., Martus, H., Wei, J. Y. and Vijg, J. (1995). Spontaneous and X-ray-induced deletion mutations in a LacZ plasmid-based transgenic mouse model. Mutation Research, 331, 8997.
  • Goto, M. (1997). Hierarchical deterioration of body systems in Werner's syndrome: implications for normal ageing. Mechanisms of Ageing and Development, 98, 239254.
  • Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E. and Baylin, S. B. (1995). E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Research, 22, 51955199.
  • Grawé, J., Abramsson-Zetterberg, L. and Zetterberg, G. (1998). Low dose effects of chemicals as assessed by the flow cytometric in vivo micronucleus assay. Mutation Research, 405, 199208.
  • Grawé, J., Biko, J., Lorenz, R., Reiners, C., Stopper, H., Vershenya, S., Vukicevic, V. and Hempel, K. (2005). Evaluation of the reticulocyte micronucleus assay in patients treated with radioiodine for thyroid cancer. Mutation Research, 583, 1225.
  • Green, M. H. (1978). Mechanisms of bacterial mutagenesis and properties of mutagenesis tester strains. Archives of Toxicology, 39, 241248.
  • Greene, N. (2002). Computer systems for the prediction of toxicity: an update. Advanced Drug Delivery Reviews, 54, 417431.
  • Greenwood, S. K., Hill, R. B., Sun, J. T., Armstrong, M. J., Johnson, T. E., Gara, J. P. and Galloway, S. M. (2004). Population doubling: a simple and more accurate estimation of cell growth suppression in the in vitro assay for chromosomal aberrations that reduces irrelevant positive results. Environmental and Molecular Mutagenesis, 43, 3644.
  • Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H. and de Lange, T. (1999). Mammalian telomeres end in a large duplex loop. Cell, 4, 503514.
  • Gu, H., Marth, J. D., Orban, P. C., Mossmann, H. and Rajewsky, K. (1994). Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science, 265, 103106.
  • Guengerich, F. P., Gillan, E. M. J. and Shimada, T. (1996). New application of bacterial systems to problems in toxicology. Critical Reviews in Toxicology, 26, 551583.
  • Gyorffy, E., Anna, L., Kovács, K., Rudnai, P. and Schoket, B. (2008). Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts. Mutagenesis, 23, 118.
  • Hahn, W. C. and Weinberg, R. A. (2002). Modelling the molecular circuitry of cancer. Nature Reviews: Cancer, 5, 331341.
  • Haigis, K. M. and Dove, W. F. (2003). A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity. Nature Genetics, 33, 3339.
  • Hakura, A., Sonoda, J., Tsutsui, Y., Mikami, T., Imade, T., Shimada, M., Yaguchi, S., Yamanaka, M., Tomimatsu, M. and Tsukidate, K. (1998). Toxicity profile of benzo[a]pyrene in the male LacZ transgenic mouse (MutaMouse) following oral administration for 5 consecutive days. Regulatory Toxicology and Pharmacology, 27, 273279.
  • Hakura, A., Tsutsui, Y., Sonoda, J., Tsukidate, K., Mikami, T. and Sagami, F. (2000). Comparison of the mutational spectra of the lacZ transgene in four organs of the MutaMouse treated with benzo[a]pyrene: target organ specificity. Mutation Research, 447, 239247.
  • Hamilton, M. L., Van Remmen, H., Drake, J. A., Yang, H., Guo, Z. M., Kewitt, K., Walter, C. A. and Richardson, A. (2001). Does oxidative damage to DNA increase with age? Proceedings of the National Academy of Sciences, 98, 1046910474.
  • Hansen, L. A., Spalding, J. W., French, J. E. and Tennant, R. W. (1995). A spontaneous mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event. In McClain, R. M., Slaga, T. J., Le Boeuf, R. and Pitot, H. C. (Eds), Growth Factors and Tumor Promotion: Implications for Risk Assessment. Wiley-Liss, Inc., New York, pp. 223235.
  • Harada, Y. N., Shiomi, N., Koike, M., Ikawa, M., Okabe, M., Hirota, S., Kitamura, Y., Kitagawa, M., Matsunaga, T., Nikaido, O. and Shiomi, T. (1999). Postnatal growth failure, short lifespan, and early onset of cellular senescence and subsequent immortalization in mice lacking the xeroderma pigmentosum group G gene. Molecular and Cellular Biology, 19, 23662372.
  • Harley, C. B., Futcher, A. B. and Greider, C. W. (1990). Telomeres shorten during ageing of human fibroblasts. Nature, 345, 458460.
  • Harley, V. R. and Goodfellow, P. N. (1994). The biochemical role of SRY in sex determination. Molecular Reproduction and Development, 39, 184193.
  • Harper, S. B., Dertinger, S. D., Bishop, M. E., Lynch, A. M., Lorenzo, M., Saylor, M. and MacGregor, J. T. (2007). Flow cytometric analysis of micronuclei in peripheral blood reticulocytes. III. An efficient method of monitoring chromosomal damage in the beagle dog. Toxicological Sciences, 100, 406414.
  • Harrod, V. L., Howard, T. A., Zimmerman, S. A., Dertinger, S. D. and Ware, R. E. (2007). Quantitative analysis of Howell-Jolly bodies in children with sickle cell disease. Experimental Hematology, 35, 179183.
  • Hartmann, A., Agurell, E., Beevers, C., Brendler-Schwaab, S., Burlinson, B., Clay, P., Collins, A., Smith, A., Speit, G., Thybaud, V. and Tice, R. R. (2003). Recommendations for conducting the in vivo alkaline Comet assay. Mutagenesis, 18, 4551.
  • Hartmann, A., Schumacher, M., Plappert-Helbig, U., Lowe, P., Suter, W. and Mueller, L. (2004). Use of the alkaline in vivo Comet assay for mechanistic genotoxicity investigations. Mutagenesis, 19, 5159.
  • Harvey, J. S., Howe, J. R., Lynch, A. M. and Rees, R. W. (2005). The results of five coded compounds: genistein, metaproterenol, rotenone, p-anisidine and resorcinol tested in the pH 6.7 Syrian hamster embryo cell morphological transformation assay. Mutagenesis, 20, 5156.
  • Harvey, M., McAruthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A. and Donehower, L. A. (1993). Spontaneous and carcinogen-induced tumourigenesis in p53-deficient mice. Nature Genetics, 5, 225229.
  • Hastwell, P. W., Chai, L.-L., Roberts, K. J., Webster, T. W., Harvey, J. S., Rees, R. W. and Walmsley, R. M. (2006). High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the greenscreen HC GADD45a-GFP genotoxicity assay. Mutation Research: Genetic Toxicology and Environmental Mutagenesis, 607, 160175.
  • Hasty, P., Campisi, J., Hoeijmakers, J., van Steeg, H. and Vijg, J. (2003). Aging and genome maintenance: lessons from the mouse? Science, 299, 13551359.
  • Hayashi, M., MacGregor, J. T., Gatehouse, D. G., Blakey, D. H., Dertinger, S. D., Abramsson-Zetterberg, L., Krishna, G., Morita, T., Russo, A., Asano, N., Suzuki, H., Ohyama, W. and Gibson, D.; In Vivo Micronucleus Assay Working Group, IWGT (2007). In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test. Mutation Research, 627, 1030.
  • Heddle, J. (1973). A rapid in vivo test for chromosome damage. Mutation Research, 18, 187190.
  • Helton, E. S. and Chen, X. (2007). p53 modulation of the DNA damage response. Journal of Cellular Biochemistry, 100, 883896.
  • Hilliard, C. A., Armstrong, M. J., Bradt, C. I., Hill, R. B., Greenwood, S. K. and Galloway, S. M. (1998). Chromosome aberrations in vitro related to cytotoxicity of non-mutagenic chemicals and metabolic poisons. Environmental and Molecular Mutagenesis, 31, 316326.
  • Hilliard, C., Hill, R., Armstrong, M., Fleckenstein, C., Crowley, J., Freeland, E., Duffy, D. and Galloway, S. M. (2007). Chromosome aberrations in Chinese hamster and human cells: a comparison using compounds with various genotoxicity profiles. Mutation Research, 616, 103118.
  • Hoeijmakers, J. H. (2001). Genome maintenance mechanisms for preventing cancer. Nature, 411, 366374.
  • Holmstrom, L. M., Palmer, A. K. and Favor, J. (1993). The rodent dominant lethal assay. In Kirkland, D. J. and Fox, M. (Eds), Supplementary Mutagenicity Tests: UKEM Recommended Procedures. UKEMS Subcommittee on Guidelines for Mutagenicity Testing, Report, Part II Revised. Cambridge University Press, Cambridge, pp. 129156.
  • Holzhutter, H. G. (1997). A general measure of in vitro phototoxicity derived from pairs of dose-response curves and its use in predicting the in vivo phototoxicity of chemicals. ATLA: Alternatives to Laboratory Animals, 25, 445462.
  • Hristoskova, S. (2004). Role of apoptotic and anti-apoptotic mechanisms in erythroblast differentiation. Doctor of Philosophy thesis, Philosophisch-Naturwissenshaftlichen Fakultie, University of Basel.
  • Hubbard, S. A., Green, M. H. L., Gatehouse, D. and Brig, J. W. (1984). The fluctuation test in bacteria. In Kilbey, L. M., Nichols, W. and Ramel, C. (Eds), Handbook of Mutagenicity Test Procedures, 2nd edn. Elsevier, Amsterdam, pp. 142161.
  • ICH S2A: Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals, 61 FR 18199 (1996). Federal Register, April 1996.
  • ICH S2B: A Standard Battery for Genotoxicity Testing of Pharmaceuticals, 62 FR 62472 (1997). Federal Register, November 1997.
  • Iliakis, G., Wang, Y., Guan, J. and Wang, H. (2003). DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene, 22, 58345847.
  • Ishidate, M. Jr. and Sofuni, T. (1985). The in vitro chromosomal aberration test using Chinese hamster lung (CHL) fibroblast cells in culture. In Ashby, J. de Serres, F. J., Draper, M., Ishidate, M. Jr., Margolin, B. H., Matter, B. E. and Shelby, M. D. (Eds), Progress in Mutation Research: Evaluation of Short-Term Tests for Carcinogens; Report of the International Programme on Chemical Safety's Collaborative Study on In Vitro Assays, Vol. 5, Elsevier, New York, pp. 427432.
  • Isono, K. and Yourno, J. (1974). Chemical carcinogens as frameshift mutagens: Salmonella DNA sequence sensitive to mutagenesis by polycyclic carcinogens. Proceedings of the National Academy of Sciences of the United States of America, 71, 16121617.
  • Itoh, T., Cado, D., Kamide, R. and Linn, S. (2004). DDB2 gene disruption leads to skin tumors and resistance to apoptosis after exposure to ultraviolet light but not a chemical carcinogen. Proceedings of the National Academy of Sciences, 101, 20522057.
  • Jackson, S. P. (2002). Sensing and repairing DNA double-strand breaks. Carcinogenesis, 23, 687696.
  • Jacobs, A. C., Brown, P. C., Chen, C., Ellis, A., Farrelly, J. and Osterberg, R. (2004). CDER photosafety guidance for Industry. Toxicologic Pathology, 32 (Suppl 2), 1718.
  • Jacobson-Kram, D. and Jacobs, A. (2005). Use of genotoxicity data to support clinical trial or positive genetox findings on a candidate pharmaceutical or impurity … Now what? International Journal of Toxicology, 24, 129134.
  • Jaenisch, R., Hochedlinger, K. and Eggan, K. (2005). Nuclear cloning, epigenetic reprogramming and cellular differentiation. Novartis Foundation Symposium, 265, 107118.
  • Jagger, C., Tate, M., Cahill, P. A., Hughes, C., Knight, A. W., Billinton, N. and Walmsley, R. M. (2009). Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a-GFP assay. Mutagenesis, 24, 3550.
  • Jakubczak, J. L., Merlino, G., French, J. E., Muller, W. J., Paul, B., Adhya, S. and Garges, S. (1996). Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proceedings of the National Academy of Sciences of the United States of America, 93, 90739078.
  • Jass, J. R. (2007). Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology, 50, 113130.
  • Jenkins, G. J., Doak, S. H., Johnson, G. E., Quick, E., Waters, E. M. and Parry, J. M. (2005). Do dose response thresholds exist for genotoxic alkylating agents? Mutagenesis, 20, 389398.
  • Jha, A. N. (2004). Genotoxicological studies in aquatic organisms: an overview. Mutation Research, 552, 117.
  • Johnson, C. N., Adkins, N. L. and Georgel, P. (2005). Chromatin remodeling complexes: ATP-dependent machines in action. Biochemistry and Cell Biology, 4, 405417.
  • Josephy, P. D. (2002). Genetically-engineered bacteria expressing human enzymes and their use in the study of mutagens and mutagenesis. Toxicology, 181–182, 255260.
  • Kanno, S., Oda, N., Abe, M., Terai, Y., Ito, M., Shitara, K., Tabayashi, K., Shibuya, M. and Sato, Y. (2000). Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene, 19, 21382146.
  • Karakosta, A., Golias, Ch., Charalabopoulos, A., Peschos, D., Batistatou, A. and Charalabopoulos, K. (2005). Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia. Journal of Experimental and Clinical Cancer Research, 4, 505514.
  • Karakoula, K., Suarez-Merino, B., Ward, S., Phipps, K. P., Harkness, W., Hayward, R., Thompson, D., Jacques, T. S., Harding, B., Beck, J., Thomas, D. G. and Warr, T. J. (2008). Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13. Genes, Chromosomes and Cancer, 47, 10051022.
  • Karanjawala, Z. E. and Lieber, M. R. (2004). DNA damage and aging. Mechanisms of Ageing and Development, 125, 405416.
  • Kasper, P., Aeby, P., Brendler-Schwaab, S., Epe, B., Froetschl, R., Hertel, C., Kirchner, S., Meurer, K., Plappert-Helbig, U. and Schmidt, E. (2005). Photochemical genotoxicity testing in vitro: a European collaborative study on the comet assay and the micronucleus test. Mutation Research, 577 (Suppl 1), e170 (abstract 547).
  • Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B. and Fornace, A. J. Jr. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71, 587597.
  • Kennelly, J. C., Waters, R., Ashby, J., Lefevre, P. A., Burlinson, B., Benford, D. J., Dean, S. W. and De Gray Mitchell, I. (1993). In vivo rat liver UDS assay. In Kirkland, D. J. and Fox, M. (Eds), Supplementary Mutagenicity Tests: UKEM Recommended Procedures. UKEMS Subcommittee on Guidelines for Mutagenicity Testing, Report, Part II Revised. Cambridge University Press, Cambridge, pp. 5277.
  • Kenyon, J. and Gerson, S. L. (2007). The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Research, 35, 75577565.
  • Kerckaert, G. A., LeBoeuf, R. A. and Isfort, R. J. (1998). Assessing the predictivity of the Syrian hamster embryo cell transformation assay for determining the rodent carcinogenic potential of single ring aromatic/nitro aromatic amine compounds. Toxicological Sciences, 41, 189197.
  • Kersten, B., Zhang, J., Brendler-Schwaab, S. Y., Kasper, P. and Müller, L. (1999). The application of the micronucleus test in Chinese hamster V79 cells to detect drug-induced photogenotoxicity. Mutation Research, 445, 5571.
  • Khanna, K. K. and Jackson, S. P. (2001). DNA double-strand breaks: signaling, repair and the cancer connection. Nature Genetics, 27, 247254.
  • Kirkland, D. K. (1989). Statistical Evaluation of Mutagenicity Test Data. Cambridge University Press, Cambridge.
  • Kirkland, D. K. (1990). Basic Mutagenicity Tests—UKEMS Recommended Procedures. Cambridge University Press, Cambridge.
  • Kirkland, D. K. (1992). Chromosomal aberration tests in vitro: problems with protocol design and interpretation of results. Mutagenesis, 7, 95106.
  • Kirkland, D. (1994). Preface. Mutation Research, 312, 195199.
  • Kirkland, D., Aardema, M., Henderson, L. and Muller, L. (2005). Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens: I. Sensitivity, specificity and relative predictivity. Mutation Research, 584, 1256.
  • Kirkland, D., Aardema, M., Müller, L. and Hayashi, M. (2006). Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens: II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Mutation Research, 608, 2942.
  • Kirkland, D. K. and Fox, M. (1993). Supplementary Mutagenicity Tests—UKEMS Recommended Procedures. Cambridge University Press, Cambridge.
  • Kirkland, D. and Müller, L. (2000). Interpretation of the biological relevance of genotoxicity test results: the importance of thresholds. Mutation Research, 464, 137147.
  • Kirkland, D., Pfuhler, S., Tweats, D., Aardema, M., Corvi, R., Darroudi, F., Elhajouji, A., Glatt, H., Hastwell, P., Hayashi, M., Kasper, P., Kirchner, S., Lynch, A., Marzin, D., Maurici, D., Meunier, J. R., Müller, L., Nohynek, G., Parry, J., Parry, E., Thybaud, V., Tice, R., van Benthem, J., Vanparys, P. and White, P. (2007). How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM workshop. Mutation Research, 628, 3155.
  • Kirkland, D. and Speit, G. (2008). Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens: III. Appropriate follow-up testing in vivo. Mutation Research, 654, 114132.
  • Kirkwood, T. B. and Holliday, R. (1979). The evolution of ageing and longevity. Proceedings of the Royal Society of London, Series B: Biological Sciences, 205, 531546.
  • Kirsch-Volders, M. (1997). Towards a validation of the micronucleus test. Mutation Research, 392, 14.
  • Kirsch-Volders, M., Sofuni, T., Aardema, M., Albertini, S., Eastmond, D., Fenech, M., Ishidate, M. Jr., Lorge, E., Norppa, H., Surralles, J., von der Hude, W. and Wakata, A. (2000b). Report from the in vitro micronucleus assay working group. Environmental and Molecular Mutagenesis, 35, 167172.
  • Kirsch-Volders, M., Sofuni, T., Aardema, M., Albertini, S., Fenech, M., Ishidate, M. Jr., Kirchner, S., Lorge, E., Morita, T., Norppa, H., Surralles, J., Vanhauwaert, A. and Wakata, A. (2003a). Report from the in vitro micronucleus assay working group. Mutation Research, 540, 153163.
  • Kirsch-Volders, M., Vanhauwaert, A., Eichenlaub-Ritter, U. and Decordier, I. (2003b). Indirect mechanisms of genotoxicity. Toxicology Letters, 140–141, 6374.
  • Klungland, A., Rosewell, I., Hollenbach, S., Larsen, E., Daly, G., Epe, B., Seeberg, E., Lindahl, T. and Barnes, D. E. (1999). Accumulation of pre-mutagenic DNA lesions in mice defective in removal of oxidative base damage. Proceedings of the National Academy of Sciences of the United States of America, 96, 1330013305.
  • Knight, A. W., Billinton, N., Cahill, P. A., Scott, A., Harvey, J. S., Roberts, K. J., Tweats, D. J., Keenan, P. O. and Walmsley, R. M. (2007). An analysis of results from 305 compounds tested with the yeast RAD54-GFP genotoxicity assay (GreenScreen GC) - including relative predictivity of regulatory tests and rodent carcinogenesis and performance with autofluorescent and coloured compounds. Mutagenesis, 22, 409416.
  • Knudson, A. G. (1971). Mutation and cancer. A statistical study of retinoblastoma. Proceedings of the National Academy of Sciences, 68, 820823.
  • Koch, W. H., Henrikson, E. N. and Cebula, T. A. (1996). Molecular analysis of Salmonella hisG428 ochre revertants for rapid characterization of mutational specificity. Mutagenesis, 11, 341348.
  • Koh, J., Bartlett, R. J., Pericak-Vance, M. A., Speer, M. C., Yamaoka, L. H., Phillips, K., Hung, W.-Y., Ray, P. N., Worton, R. G., Gilbert, J. R., Lee, J. E., Siddique, T., Kandt, R. S. and Roses, A. D. (1987). Inherited deletion at Duchenne dystrophy locus in normal male. (Letter.) Lancet, 2, 11541155.
  • Kohler, S. W., Provost, G. S., Fieck, A., Kretz, P. L., Bullock, W. O., Putman, D. L., Sorge, J. A. and Short, J. M. (1991). Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector. Environmental and Molecular Mutagenesis, 18, 316321.
  • Kohn, K. W. (1999). Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Molecular Biology of the Cell, 8, 27032734.
  • Kondo, S., Ichikawa, H., Iwo, K. and Kato, T. (1970). Base change mutagenesis and prophage induction in strains of Escherichia coli with different DNA repair capacities. Genetics, 66, 167217.
  • Koratkar, R., Pequignot, E., Hauck, W. W. and Siracusa, L. D. (2002). The CAST/Ei strain confers significant protection against Apc(Min) intestinal polyps, independent of the resistant modifier of Min 1 (Mom1) locus. Cancer Research, 62, 54135417.
  • Kroes, R. and Kozianowski, G. (2002). Threshold of toxicological concern (TTC) in food safety assessment. Toxicology Letters, 127, 4346.
  • Kumaravel, T. S. and Bristow, R. G. (2005). Detection of genetic instability at HER-2/neu and p53 loci in breast cancer cells using Comet-FISH. Breast Cancer Research and Treatment, 91, 8993.
  • Kung, A. L., Sherwood, S. W. and Schimke, R. T. (1990a). Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proceedings of the National Academy of Sciences of the United States of America, 87, 95539557.
  • Kung, A. L., Zetterberg, A., Sherwood, S. W. and Schimke, R. T. (1990b). Cytotoxic effects of cell cycle phase specific agents: result of cell cycle perturbation. Cancer Research, 50, 73077317.
  • Kunkel, T. A. and Erie, D. A. (2005). DNA mismatch repair. Annual Review of Biochemistry, 74, 681710.
  • Lambert, I. B., Singer, T. M., Boucher, S. E. and Douglas, G. R. (2005). Detailed review of transgenic rodent mutation assays. Mutation Research, 590, 1280.
  • Lamlum, H., Ilyas, M., Rowan, A., Clark, S., Johnson, V., Bell, J., Frayling, I., Efstathiou, J., Pack, K., Payne, S., Roylance, R., Gorman, P., Sheer, D., Neale, K., Phillips, R., Talbot, I., Bodmer, W. and Tomlinson, I. (1999). The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's ‘two-hit’ hypothesis. Nature Medicine, 5, 10711075.
  • Lasarow, R. M., Isseroff, R. R. and Gomez, E. C. (1992). Quantitative in vitro assessment of phototoxicity by a fibroblast-neutral red assay. The Journal of Investigative Dermatology, 98, 725729.
  • Leach, E. G., Narayanan, L., Havre, P. A., Gunther, E. J., Yeasky, T. M. and Glazer, P. M. (1996). Tissue specificity of spontaneous point mutations in lambda supF transgenic mice. Environmental and Molecular Mutagenesis, 28, 459464.
  • LeBoeuf, R. A., Kerckaert, G. A., Aardema, M. J. and Gibson, D. P. (1990). Multistage neoplastic transformation of Syrian hamster embryo cells cultured at pH 6.70. Cancer Research, 50, 37223729.
  • LeBoeuf, R. A., Kerckaert, G. A., Aardema, M. J., Gibson, D. P., Brauninger, R. and Isfort, R. J. (1996). The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals. Mutation Research, 356, 85127.
  • Levin, D. E., Yamasaki, E. and Ames, B. N. (1982). A new Salmonella tester strain, TA97, for the detection of frameshift mutagens. A run of cytosines as a mutational hot-spot. Mutation Research, 94, 315330.
  • Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H. and Parsons, R. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 19431946.
  • Lieber, M. R., Ma, Y., Pannicke, U. and Schwarz, K. (2003). Mechanism and regulation of human non-homologous DNA end-joining. Nature Reviews: Molecular Cell Biology, 4, 712720.
  • Lim, J. L. and Stern, R. S. (2005). High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. The Journal of Investigative Dermatology, 124, 505513.
  • Little, J. (1993). The Chernobyl accident, congenital anomalies and other reproductive outcomes. Paediatric and Perinatal Epidemiology, 7, 121151.
  • Loeb, L. A. (1991). Mutator phenotype may be required for multistage carcinogenesis. Cancer Research, 51, 30753079.
  • Lombard, D. B., Beard, C., Johnson, B., Marciniak, R. A., Dausman, J., Bronson, R., Buhlmann, J. E., Lipman, R., Curry, R., Sharpe, A., Jaenisch, R. and Guarente, L. (2000). Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Molecular and Cellular Biology, 20, 32863291.
  • Lorge, E., Thybaud, V., Aardema, M. J., Oliver, J., Wakata, A., Lorenzon, G. and Marzin, D. (2006). SFTG international collaborative study on in vitro micronucleus test. I. General conditions of the study. Mutation Research, 607, 1336.
  • Lovell, D. P. (2000). Dose-response and thresholds-mediated mechanisms in mutagenesis: statistical models and study design. Mutation Research, 464, 8795.
  • Lovell, D. P., Thomas, G. and Dubow, R. (1999). Issues related to the experimental design and subsequent analysis of in vivo and in vitro comet studies. Teratogenesis, Carcinogenesis, and Mutagenesis, 19, 109119.
  • Lu, J., Getz, G., Miska, E. A., Varez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., Downing, J. R., Jacks, T., Horvitz, H. R. and Golub, T. R. (2005). MicroRNA expression profiles classify human cancers. Nature, 7043, 834838.
  • van der Luijt, R. B., Meera Khan, P., Vasen, H. F., Breukel, C., Tops, C. M., Scott, R. J. and Fodde, R. (1996). Germline mutations in the 3′ part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli. Human Genetics, 98, 727734.
  • Luria, S. E. and Delbruck, M. (1943). Mutations of bacteria from virus sensitivity to virus resistance. Genetics, 28, 491511.
  • Lutz, W. (1998). Dose-response relationship in chemical carcinogenesis; superposition of different mechanisms of action, resulting in linear non-linear curves, practical thresholds, J-shapes. Mutation Research, 405, 117124.
  • Lynch, A. M. and Connelly, J. (2003). The toxicologist's view: non-clinical safety assessment. In Edwards, M. (Ed.), Experimental Therapeutics. Martin Dunitz, London, pp. 2550.
  • Lynch, A., Harvey, J., Aylott, M., Nicholas, E., Burman, M., Siddiqui, A., Walker, S. and Rees, R. (2003). Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity. Mutagenesis, 18, 345353.
  • Lynch, A. M., Mahabir, A. G., Bradford, A., Brockhurst, K., van Benthem, J., van Steeg, H. and Rees, R. W. (2008a). Is Muta™Mouse insensitive to clastogens? Mutation Research, 652, 145150.
  • Lynch, A. M., Robinson, S. A., Wilcox, P., Smith, M. D., Kleinman, M., Jiang, K. and Rees, R. W. (2008b). Cycloheximide and disulfoton are positive in the photoclastogenecity assay but do not absorb UV irradiation: another example of pseudophotoclastogenicity? Mutagenesis, 23, 111118.
  • Lynch, A. M., Murray, S., Boobis, A. R., Davies, D. S. and Gooderham, N. J. (1991). The measurement of MeIQx adducts with mouse haemoglobin in vitro and in vivo: implications for human dosimetry. Carcinogenesis, 12, 10671072.
  • Lynch, A. M., Murray, S., Zhao, K., Gooderham, N. J., Boobis, A. R. and Davies, D. S. (1993). Molecular dosimetry of the food-borne carcinogen MeIQx using adducts of serum albumin. Carcinogenesis, 14, 191194.
  • Lynch, A. M. and Parry, J. M. (1993). The cytochalasin-B micronucleus/kinetochore assay in vitro: studies with 10 suspected aneugens. Mutation Research, 287, 7186.
  • MacGregor, J. T., Bishop, M. E., McNamee, J. P., Hayashi, M., Asano, N., Wakata, A., Nakajima, M., Saito, J., Aidoo, A., Moore, M. M. and Dertinger, S. D. (2006). Flow cytometric analysis of micronuclei in peripheral blood reticulocytes: II. An efficient method of monitoring chromosomal damage in the rat. Toxicological Sciences, 94, 92107.
  • MacGregor, J. T., Wehr, C. M., Hiatt, R. A., Peters, B., Tucker, J. D., Langlois, R. G., Jacob, R. A., Jensen, R. H., Yager, J. W., Shigenaga, M. K., Frie, B., Eynon, B. P. and Ames, B. N. (1997). ‘Spontaneous’ genetic damage in man: evaluation of interindividual variability, relationship among markers of damage, and influence of nutritional status. Mutation Research, 377, 125135.
  • MacPhee, D. G. (1989). Development of bacterial mutagenicity tests: a view from afar. Environmental and Molecular Mutagenesis, 14, 3538.
  • MacPhee, M., Chepenik, K. P., Liddell, R. A., Nelson, K. K., Siracusa, L. D. and Buchberg, A. M. (1995). The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell, 81, 957966.
  • Madle, S., Dean, S. W., Andrae, U., Brambilla, G., Burlinson, B., Doolittle, D. J., Furihata, C., Hertner, T., McQueen, C. A. and Mori, H. (1994). Recommendations for the performance of UDS tests in vitro and in vivo. Mutation Research, 312, 263285.
  • Mahmoud, N. N., Boolbol, S. K., Bilinski, R. T., Martucci, C. M., Chadburn, A. and Betagnolli, M. M. (1997). Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration. Cancer Research, 57, 50455050.
  • Mahon, G. A. T., Green, M. H. L., Middleton, B., Mitchell, I.de G., Robinson, W. D. and Tweats, D. J. (1989). Analysis of data from microbial colony assays. In Kirkland, D. J. (Ed.), Statistical Evaluation of Mutagenicity Test Data. UKEMS Subcommittee on Guidelines for Mutagenicity Testing, Report, Part III. Cambridge University Press, Cambridge, pp. 2865.
  • Malumbres, M. and Barbacid, M. (2001). To cycle or not to cycle: a critical decision in cancer. Nature Reviews: Cancer, 3, 222231.
  • Malumbres, M. and Barbacid, M. (2005). Mammalian cyclin-dependent kinases. Trends in Biochemical Sciences, 30, 630641.
  • Margison, G. P., Santibáñez Koref, M. F. and Povey, A. C. (2002). Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine. Mutagenesis, 17, 483487.
  • Maron, D. M. and Ames, B. N. (1983). Revised methods for the salmonella mutagenicity test. Mutation Research, 113, 173215.
  • Mathieu, N., Pirzio, L., Freulet-Marriere, M. A., Desmaze, C. and Sabatier, L. (2004). Telomeres and chromosomal instability. Cellular and Molecular Life Sciences, 61, 641656.
  • Matter, B. and Schmid, W. (1971). Trenimon-induced chromosomal damage in bone marrow cells of six mammalian species, evaluated by the micronucleus test. Mutation Research, 12, 417425.
  • Matthews, E. J., Kruhlak, N. L., Cimino, M. C., Benz, R. D. and Contrera, J. F. (2006a). An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints. Regulatory Toxicology and Pharmacology, 44, 8396.
  • Matthews, E. J., Kruhlak, N. L., Cimino, M. C., Benz, R. D. and Contrera, J. F. (2006b). An analysis of genotoxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods. Regulatory Toxicology and Pharmacology, 44, 97110.
  • Mattick, J. S. and Makunin, I. V. (2006). Non-coding RNA. Human Molecular Genetics, 15, R17R29.
  • Maurer, T. (1987). Phototoxicity testing—in vivo and in vitro. Food and Chemical Toxicology, 25, 407414.
  • Mauthe, R. J., Gibson, D. P., Bunch, R. T. and Custer, L. (2001). The Syrian hamster embryo (SHE) cell transformation assay. Review of the methods and results. Toxicologic Pathology, 29 (Suppl), 138146.
  • Mayer, J., Cheeseman, M. A. and Twaroski, M. L. (2008). Structure-activity relationship analysis tools: validation and applicability in predicting carcinogens. Regulatory Toxicology and Pharmacology, 50, 5058.
  • McCulloch, S. D. and Kunkel, T. A. (2008). The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Research, 18, 148161.
  • McDonald, E. R. III and El-Deiry, W. S. (2000). Cell cycle control as a basis for cancer drug development (Review). International Journal of Oncology, 16, 871886.
  • McGovern, T. and Jacobson-Kram, D. (2006). Regulation of genotoxic and carcinogenic impurities in drug substances and products. Trends in Analytical Chemistry, 25, 790795.
  • McGregor, D. B., Edwards, I., Riach, C. G., Cattanach, P., Martin, P., Mitchell, A. and Caspary, W. J. (1988). Studies of an S9-based metabolic activation system used in the mouse lymphoma L5178Y cell mutation assay. Mutagenesis, 3, 485490.
  • McKenna, D. J., McKeown, S. R. and McKelvey-Martin, V. J. (2008). Potential use of the comet assay in the clinical management of cancer. Mutagenesis, 23, 183190.
  • McKenna, D. J., Rajab, N. F., McKeown, S. R., McKerr, G. and McKelvey-Martin, V. J. (2003). Use of the comet-FISH assay to demonstrate repair of the TP53 gene region in two human bladder carcinoma cell lines. Radiation Research, 159, 4956.
  • McKusick, V. A. (2006). A 60-year tale of spots, maps, and genes. Annual Review of Genomics and Human Genetics, 7, 127.
  • Meek, D. W. (2004). The p53 response to DNA damage. DNA Repair, 3, 10491056.
  • Melnikova, V. O. and Ananthaswamy, H. N. (2005). Cellular and molecular events leading to the development of skin cancer. Mutation Research, 571, 91106.
  • Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B. and Sidransky, D. (1995). 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine, 7, 686692.
  • Meunier, J. R., Sarasin, A. and Marrot, L. (2002). Photogenotoxicity of mammalian cells: a review of the different assays for in vitro testing. Photochemistry and Photobiology, 75, 437447.
  • Michor, F., Iwasa, Y., Vogelstein, B., Lengauer, C. and Nowak, M. A. (2005). Can chromosomal instability initiate tumorigenesis? Seminars in Cancer Biology, 15, 4349.
  • Miller, B., Albertini, S., Locher, F., Thybaud, V. and Lorge, E. (1997). Comparative evaluation of the in vitro micronucleus test and the in vitro chromosome aberration test: industrial experience. Mutation Research, 392, 4559.
  • Miller, B., Potter-Locher, F., Seelbach, A., Stopper, H., Utesch, D. and Madle, S. (1998). Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM working group on the in vitro micronucleus test. Gesellschaft für Umwelt-Mutations-forschung. Mutation Research, 410, 81116.
  • Mirza, A., Wu, Q., Wang, L., McClanahan, T., Bishop, W. R., Gheyas, F., Ding, W., Hutchins, B., Hockenberry, T., Kirschmeier, P., Greene, J. R. and Liu, S. (2003). Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression. Oncogene, 23, 36453654.
  • de Mitchell, I. G. and Combes, R. D. (1984). Mutation tests with the fruit fly Drosophila melanogaster. In Venitt, S. and Parry, J. M. (Eds), Mutagenicity Testing—a Practical Approach. IRL Press, Oxford, pp. 149185.
  • Mitchell, I. D., Lambert, T. R., Burden, M., Sunderland, J., Porter, R. L. and Carlton, J. B. (1995). Is polyploidy an important genotoxic lesion? Mutagenesis, 10, 7983.
  • Moore, M. M., Clive, D., Howard, B. E., Batson, A. G. and Turner, N. T. (1985). Analysis of TFTr mutants of L5178Y/TK+/− mouse lymphoma cells. Mutation Research, 151, 161174.
  • Moore, M. M., Honma, M., Clements, J., Awogi, T., Bolcsfoldi, G., Cole, J., Gollapudi, B., Harrington-Brock, K., Mitchell, A., Muster, W., Myhr, B., O'Donovan, M., Ouldelhkim, M. C., San, R., Shimada, H. and Stankowski, L. F. Jr. (2000). Mouse lymphoma thymidine kinase locus gene mutation assay: International Workshop on Genotoxicity Test Procedures Workgroup Report. Environmental and Molecular Mutagenesis, 35, 185190.
  • Moore, M. M., Honma, M., Clements, J., Harrington-Brock, K., Awogi, T., Bolcsfoldi, G., Cifone, M., Collard, D., Fellows, M., Flanders, K., Gollapudi, B., Jenkinson, P., Kirby, P., Kirchner, S., Kraycer, J., McEnaney, S., Muster, W., Myhr, B., O'Donovan, M., Oliver, J., Ouldelhkim, M. C., Pant, K., Preston, R., Riach, C., San, R., Shimada, H. and Stankowski, L. F. Jr. (2002). Mouse lymphoma thymidine kinase gene mutation assay: follow-up International Workshop on Genotoxicity Test Procedures, New Orleans, Louisiana, April 2000. Environmental and Molecular Mutagenesis, 40, 292299.
  • Moore, M. M., Honma, M., Clements, J., Bolcsfoldi, G., Cifone, M., Delongchamp, R., Fellows, M., Gollapudi, B., Jenkinson, P., Kirby, P., Kirchner, S., Muster, W., Myhr, B., O'Donovan, M., Oliver, J., Omori, T., Ouldelhkim, M. C., Pant, K., Preston, R., Riach, C., San, R., Stankowski, L. F. Jr., Thakur, A., Wakuri, S. and Yoshimura, I., Mouse Lymphoma Assay Workgroup. (2003). Mouse lymphoma thymidine kinase gene mutation assay: International Workshop on Genotoxicity Tests Workgroup Report—Plymouth, UK 2002. Mutation Research, 540, 127140.
  • Moore, M. M., Honma, M., Clements, J., Bolcsfoldi, G., Burlinson, B., Cifone, M. G., Clarke, J., Delongchamp, R., Durword, R., Fellows, M. D., Gollapudi, B., Hou, S., Jenkinson, P., Lloyd, M., Majeska, J., Myhr, B., O'Donovan, M., Omori, T., Riach, C., San, R., Stankowski, L. F. Jr., Thakur, A. K., Van Goethem, F., Wakuri, S. and Yoshimura, I. (2006). Mouse lymphoma thymidine kinase gene mutation assay: follow-up meeting of the International Workshop on Genotoxicity Testing—Aberdeen, Scotland, 2003—assay acceptance criteria, positive controls, and data evaluation. Environmental and Molecular Mutagenesis, 47, 15.
  • Moore, M. M., Honma, M., Clements, J., Bolcsfoldi, G., Burlinson, B., Cifone, M., Clarke, J., Clay, P., Doppalapudi, R., Fellows, M., Gollapudi, B., Hou, S., Jenkinson, P., Muster, W., Pant, K., Kidd, D. A., Lorge, E., Lloyd, M., Myhr, B., O'Donovan, M., Riach, C., Stankowski, L. F. Jr., Thakur, A. K., Van Goethem, F., Mouse Lymphoma Assay Workgroup, IWGT. (2007). Mouse lymphoma thymidine kinase gene mutation assay: meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005, recommendations for 24-h treatment. Mutation Research, 627, 3640.
  • Moore, M. M. and Howard, B. B. (1982). Quantitation of small colony trifluorothymidine-resistant mutants of L5178Y/TK+/− mouse lymphoma cells in RPMI-1640 medium. Mutation Research, 104, 287294.
  • Mortlemans, K. and Riccio, E. (2000). The Escherichia coli WP2 tryptophan reverse mutation assay. Mutation Research, 455, 6169.
  • Mortlemans, K. and Zeiger, E. (2000). The Ames Salmonella/microsome mutagenicity assay. Mutation Research, 455, 2960.
  • Moser, A. R., Pitot, H. C. and Dove, M. F. (1990). A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322324.
  • Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L. and Wu, J. R. (1988). A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proceedings of the National Academy of Sciences, 18, 66226626.
  • Muehlbauer, P. A., Spellman, R. A., Gunther, W. C., Sanok, K. E., Wiersch, C. J., O'Lone, S. D., Dobo, K. L. and Schuler, M. J. (2008). Improving dose selection and identification of aneugens in the in vitro chromosome aberration test by integration of flow cytometry-based methods. Environmental and Molecular Mutagenesis, 49, 318327.
  • Muller, H. J. (1927). Artificial transmutation of the gene. Science, 66, 8487.
  • Müller, L., Kikuchi, Y., Probst, G., Schechtman, L., Shimada, H., Sofuni, T. and Tweats, D. (1999). ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact. Mutation Research, 436, 195225.
  • Müller, L., Mauthe, R. J., Riley, C. M., Andino, M. M., Antonis, D. D., Beels, C., DeGeorge, J., De Knaep, A. G., Ellison, D., Fagerland, J. A., Frank, R., Fritschel, B., Galloway, S., Harpur, E., Humfrey, C. D., Jacks, A. S., Jagota, N., Mackinnon, J., Mohan, G., Ness, D. K., O'Donovan, M. R., Smith, M. D., Vudathala, G. and Yotti, L. (2006). A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. Regulatory Toxicology and Pharmacology, 44, 198221.
  • Müller, L., Gocke, E., Larson, P., Lavé, T. and Pfister, T. (2008). Elevated ethyl methanesulfonate (EMS) in nelfinavir mesylate (Viracept®, Roche): animal studies confirm toxicity threshold and absence of risk to patients. Poster LBPE1157, XVII International AIDS Conference 3–8 August, 2008, Mexico City, Mexico.
  • Munro, I. C. (1990). Safety assessment procedures for indirect food additives: an overview. Report of a workshop. Regulatory Toxicology and Pharmacology, 12, 212.
  • Muster, W., Breidenbach, A., Fischer, H., Kirchner, S., Müller, L. and Pähler, A. (2008). Computational toxicology in drug development. Drug Discovery Today, 13, 303310.
  • Myhr, B. C. and Zhang, H. (2000). Application of the in vitro SHE cell assay to the prediction of rodent carcinogenesis. Abstracts from EEMS-2000 (30th Annual Meeting of the European Environmental Mutagen Society), Budapest, Hungary. p. 80.
  • Nakamura, Y., Nishisho, I., Kinzler, K. W., Vogelstein, B., Miyoshi, Y., Miki, Y., Ando, H., Horii, A. and Nagase, H. (1991). Mutations of the adenomatous polyposis coli gene in familial polyposis coli patients and sporadic colorectal tumors. Princess Takamatsu Symposia, 22, 285292.
  • Nakane, H., Takeuchi, S., Yuba, S., Saijo, M., Nakatsu, Y., Murai, H., Nakatsuru, Y., Ishikawa, T., Hirota, S., Kitamura, Y., Kato, Y., Tsunoda, Y., Miyauchi, H., Horio, T., Tokunaga, T., Matsunaga, T., Nikaido, O., Nishimune, Y., Okada, Y. and Tanaka, K. (1995). High incidence of ultraviolet-B or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature, 377, 165168.
  • Neumann, H. G. (1988). Biomonitoring of aromatic amines and alkylating agents by measuring haemoglobin adducts. International Archives of Occupational and Environmental Health, 60, 151155.
  • Nohmi, T., Katoh, M., Suzuki, H., Matsui, M., Yamada, M., Watanabe, M., Suzuki, M., Horiya, N., Ueda, O., Shibuya, T., Ikeda, H. and Sofuni, T. (1996). A new transgenic mouse mutagenesis test system using Spi- and 6-thioguanine selections. Environmental and Molecular Mutagenesis, 28, 465470.
  • Nurse, P. (1997). Regulation of the eukaryotic cell cycle. European Journal of Cancer, 33, 10021004.
  • Nurse, P. (2002). Nobel lecture. Cyclin dependent kinases and cell cycle control. Bioscience Reports, 22, 487499.
  • Ocampo, M. T., Chaung, W., Marenstein, D. R., Chan, M. K., Altamirano, A., Basu, A. K., Boorstein, R. J., Cunningham, R. P. and Teebor, G. W. (2002). Targeted deletion of mNth1 reveals a novel DNA repair enzyme activity. Molecular and Cellular Biology, 22, 61116121.
  • Oda, Y., Shimada, T., Watanabe, M., Ishidate, M. and Nohmi, T. Jr. (1992). A sensitive umu test system for the detection of mutagenic nitroarenes in Salmonella typhimurium NMI011 having a high nitroreductase activity. Mutation Research, 272, 9199.
  • O'Driscoll, M. and Jeggo, P. A. (2006). The role of double-strand break repair—insights from human genetics. Nature Reviews: Genetics, 7, 4554.
  • OECD (1997a). OECD Guideline for Testing of Chemicals. Bacterial Reverse Mutation Test. Test Guideline 471. OECD, Paris. www.oecd.org/dataoecd/18/31/1948418.pdf.
  • OECD (1997b). OECD Guideline for the Testing of Chemicals. In Vitro Mammalian Chromosome Aberration Test. Test Guideline 473. OECD, Paris. www.oecd.org/dataoecd/18/33/1948434.pdf.
  • OECD (1997c). OECD Guideline for the Testing of Chemicals. Mammalian Erythrocyte Micronucleus Test. Test Guideline 474. OECD, Paris. www.oecd.org/dataoecd/18/34/1948442.pdf.
  • OECD (1997d). OECD Guideline for Testing of Chemicals. Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells In Vivo. Test Guideline 486. OECD, Paris.
  • OECD (1997e). OECD Guideline for the Testing of Chemicals. In Vitro Mammalian Cell Gene Mutation Test. Test Guideline 476. OECD, Paris. www.oecd.org/dataoecd/18/32/1948426.pdf.
  • Oertle, T. and Schwab, M. E. (2003). Nogo and its paRTNers. Trends in Cell Biology, 13, 187194.
  • Offer, T., Ho, E., Traber, M. G., Bruno, R. S., Kuypers, F. A. and Ames, B. N. (2005). A simple assay for frequency of chromosome breaks and loss (micronuclei) by flow cytometry of human reticulocytes. The FASEB Journal, 19, 485487.
  • Olive, P. L., Banath, J. P. and Durand, R. E. (1990). Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells using the ‘Comet’ assay. Radiation Research, 122, 8694.
  • Oliver, J., Meunier, J.-R., Awogi, T., Elhajouji, A., Ouldelhkim, M.-C., Bichet, N., Thybaud, V., Lorenzon, G., Marzin, D. and Lorge, E. (2006). SFTG International collaborative study on the in vitro micronucleus test. V. Using L5178Y cells. Mutation Research, 607, 125152.
  • Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C. and Taketo, M. (1995). Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proceedings of the National Academy of Sciences, 92, 44824486.
  • Ostling, O. and Johanson, K. J. (1984). Microelectrophoretic study of radiation-induced DNA damage in individual mammalian cells. Biochemical and Biophysical Research Communications, 123, 291298.
  • Otake, M., Schull, W. L. and Neel, J. V. (1990). Congenital malformations, stillbirths and early mortality among the children of atomic bomb survivors. Radiation Research, 122, 111.
  • Ozdag, H., Teschendorff, A. E., Ahmed, A. A., Hyland, S. J., Blenkiron, C., Bobrow, L., Veerakumarasivam, A., Burtt, G., Subkhankulova, T., Arends, M. J., Collins, V. P., Bowtell, D., Kouzarides, T., Brenton, J. D. and Caldas, C. (2006). Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics, 90, 14712164.
  • Papp-Szabó, E., Douglas, G. R., Coomber, B. L. and Josephy, P. D. (2003). Mutagenicity of the oral carcinogen 4-nitroquinoline-1-oxide in cultured BigBlue rat tongue epithelial cells and fibroblasts. Mutation Research, 522, 107117.
  • Parry, J. M. and Parry, E. M. (2006). The use of the in vitro micronucleus assay to detect and assess the aneugenic activity of chemicals. Mutation Research, 607, 58.
  • Parry, J. M. and Sorrs, A. (1993). The detection and assessment of the aneugenic potential of environmental chemicals: the European Community Aneuploidy Project. Mutation Research, 287, 315.
  • Parry, J. M. and Venitt, S. (1984). Mutagenicity Testing. IRL University Press, Oxford.
  • Paz, M. F., Avila, S., Fraga, M. F., Pollan, M., Capella, G., Peinado, M. A., Sanchez-Cespedes, M., Herman, J. G. and Esteller, M. (2002). Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Research, 15, 45194524.
  • Paz, M. F., Wei, S., Cigudosa, J. C., Rodriguez-Perales, S., Peinado, M. A., Huang, T. H. and Esteller, M. (2003). Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases. Human Molecular Genetics, 17, 22092219.
  • Petersen, G. M., Slack, J. and Nakamura, Y. (1991). Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology, 100, 16581664.
  • Petrini, J. H., Xiao, Y. and Weaver, D. T. (1995). DNA ligase I mediates essential functions in mammalian cells. Molecular and Cellular Biology, 15, 43034430.
  • Phillips, D. H. (1997). Detection of DNA modifications by the 32P-postlabelling assay. Mutation Research, 378, 112.
  • Phillips, D. H. and Castegnaro, M. (1993). Results of an interlaboratory trial of 32P-postlabelling. IARC Scientific Publications, 124, 3549.
  • Poirier, M. C., Santella, R. M. and Weston, A. (2000). Carcinogen macromolecular adducts and their measurement. Carcinogenesis, 21, 353359.
  • Pouget, J. P. and Mather, S. J. (2001). General aspects of the cellular response to low- and high-LET radiation. European Journal of Nuclear Medicine, 28, 541561.
  • Povirk, L. F. (1996). DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin and other enediynes. Mutation Research, 355, 7189.
  • Prasher, D. C., Eckenrode, V. K., Ward, W. W., Prendergast, F. G. and Cormier, M. J. (1992). Primary structure of the Aequorea victoria green-fluorescent protein. Gene, 111, 229233.
  • Preston, R. J., Au, W., Bender, M. A., Brewen, J. G., Carrano, A. V., Heddle, J. A., McFee, A. F., Wolff, S. and Wassom, J. S. (1981). Mammalian in vivo and in vitro cytogenetic assays. A report of the U.S. EPA's Gene-Tox program. Mutation Research, 87, 143188.
  • Pritchard, J. B., French, J. E., Davis, B. J. and Haseman, J. K. (2003). The role of transgenic mouse models in carcinogen identification. Environmental Health Perspectives, 111, 444454.
  • Puebla-Osorio, N., Lacey, D. B., Alt, F. W. and Zhu, C. (2006). Early embryonic lethality due to targeted inactivation of DNA ligase III. Molecular and Cellular Biology, 26, 39353941.
  • Quillardet, P. and Hoffnung, H. (1993). The SOS chromotest—A review. Mutation Research, 297, 235279.
  • Rasmussen, R. E. and Painter, R. B. (1966). Radiation-stimulated DNA synthesis in cultured mammalian cells. Journal of Cellular Biochemistry, 9, 1119.
  • Rekker, R. F. (1992). The history of drug research: from Overton to Hansch. Quantitative Structure: Activity Relationships, 11, 195199.
  • Reynolds, N. and Cooke, H. J. (2005). Role of the DAZ genes in male fertility. Reproductive Biomedicine Online, 10, 7280.
  • Rhee, I., Bachman, K. E., Park, B. H., Jair, K. W., Yen, R. W., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W., Baylin, S. B. and Vogelstein, B. (2002). DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature, 6880, 552556.
  • Rich, T., Allen, R. L. and Wyllie, A. H. (2000). Defying death after DNA damage. Nature, 407, 777783.
  • Riches, L. C., Lynch, A. M. and Gooderham, N. J. (2008). Early events in the mammalian response to DNA double-strand breaks. Mutagenesis, 23, 331339.
  • Richmond, T. J. (2006). Genomics: predictable packaging. Nature, 7104, 750752.
  • Richold, M., Chandley, A., Ashby, J., Gatehouse, D. G., Bootman, J. and Henderson, L. (1990). In vivo cytogenetics assays. In Kirkland, D. J. (Ed.), Basic Mutagenicity Tests: UKEMS Recommended Procedures. Cambridge University Press, Cambridge, pp. 115141.
  • Riordan, J. R., Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J., Drumm, M. L., Iannuzzi, M. C., Collins, F. S. and Tsui, L. (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science, 245, 10661073.
  • Robinson, W. D., Green, M. H. L., Cole, J., Healy, M. J. R., Garner, R. C. and Gatehouse, D. (1989). Statistical evaluation of bacterial/mammalian fluctuation tests. In Kirkland, D. J. (Ed.), Statistical Evaluation of Mutagenicity Test Data. Cambridge University Press, Cambridge, pp. 102140.
  • Rouse, J. and Jackson, S. P. (2002). Interfaces between the detection, signaling, and repair of DNA damage. Science, 297, 547551.
  • Røyrvik, E. C., Ahlquist, T., Rognes, T. and Lothe, R. A. (2007). Slip slidin' away: a duodecennial review of targeted genes in mismatch repair deficient colorectal cancer. Critical Reviews in Oncogenesis, 13, 229257.
  • Rulis, A. M. (1989). Establishing a threshold of regulation. In Bonin, J. J. and Stevenson, D. E. (Eds), Risk Assessment in Setting National Priorities. Plenum, New York, pp. 271278.
  • Russell, L. B. (1951). X-ray induced mutations in mice. Cold Spring Harbor Symposia on Quantitative Biology, 16, 327336.
  • Russell, L. B. (1984). Procedures and evaluation of the mouse spot test. In Kilbey, B. J., Legator, M., Nichols, W. and Ramel, C. (Eds), Handbook of Mutagencity Test Procedures, 2nd edn. Elsevier, Amsterdam, pp. 393403.
  • Russell, L. B., Cumming, R. B. and Hunsicker, P. R. (1989). Specific-locus mutation rates in the mouse following inhalation of ethylene oxide and the application of the results to estimation of human genetic risk. Mutation Research, 129, 381388.
  • Russell, L. B. and Major, M. H. (1957). Radiation induced presumed somatic mutations in the house mouse. Genetics, 42, 161175.
  • Sakamoto, K., Tominaga, Y., Yamauchi, K., Nakatsu, Y., Sakumi, K., Yoshiyama, K., Egashira, A., Kura, S., Yao, T., Tsuneyoshi, M., Maki, H., Nakabeppu, Y. and Tsuzuki, T. (2007). MUTYH-null mice are susceptible to spontaneous and oxidative stress induced intestinal tumorigenesis. Cancer Research, 67, 65996604.
  • Sancar, A. (2003). Structure and function of DNA photolyase and cryptochrome blue-light photoreceptors. Chemical Reviews, 103, 22032237.
  • Sánchez, I. and Dynlacht, B. D. (2005). New insights into cyclins, CDKs, and cell cycle control. Seminars in Cell and Developmental Biology, 16, 311321.
  • Sankaranarayanan, K. (1990). Some problems and considerations in the assessment of genetic risks of exposure to ionizing radiation. Progress in Clinical and Biological Research, 340 C, 233245.
  • Sasaki, Y. F., Sekihashi, K., Izumiyama, F., Nishidate, E., Saga, A., Ishida, K. and Tsuda, S. (2000). The Comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP carcinogenicity database. Critical Reviews in Toxicology, 30, 629799.
  • Schatten, H. (2008). The mammalian centrosome and its functional significance. Histochemistry and Cell Biology, 129, 667686.
  • Schlegel, R. and MacGregor, J. T. (1984). The persistence of micronucleated erythrocytes in the peripheral circulation of normal and splenectomized Fisher 344 rats: Implications for cytogenetic screening. Mutation Research, 127, 169174.
  • Schmid, W. (1975). The micronucleus test. Mutation Research, 31, 915.
  • Schmitt, E., Paquet, C., Beauchemin, M. and Bertrand, R. (2007). DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis. Journal of Zhejiang University, Science B, 8, 377397.
  • Schneiderman, M. A., Decoufle, P. and Brown, C. C. (1979). Thresholds for environmental cancer: biologic and statistical considerations. Annals of the New York Academy of Sciences, 329, 92130.
  • Scott, D., Galloway, S. M., Marshall, R. R., Ishidate, M. Jr., Brusick, D., Ashby, J. and Myhr, B. C. (1991). International Commission for Protection Against Environmental Mutagens and Carcinogens. Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9. Mutation Research, 257, 147204.
  • Sessions, J. (2007). Chronic myeloid leukemia in 2007. American Journal of Health: System Pharmacy, 64, S4S9.
  • Sharma, R. A., Farmer, P. B. (2004). Biological relevance of adduct detection to the chemoprevention of cancer. Clinical Cancer Research, 10, 49014912.
  • Shay, J. W. and Bacchetti, S. (1997). A survey of telomerase activity in human cancer. European Journal of Cancer, 5, 787791.
  • Shiloh, Y. (2003). ATM and related protein kinases: safeguarding genome integrity. Nature Reviews: Cancer, 3, 155168.
  • Shy, M. E., Siskind, C., Swan, E. R., Krajewski, K. M., Doherty, T., Fuerst, D. R., Ainsworth, P. J., Lewis, R. A., Scherer, S. S. and Hahn, A. F. (2007). CMT1X phenotypes represent loss of GJB1 gene function. Neurology, 68, 849855.
  • Signorello, L. B., Cohen, S. S., Bosetti, C., Stovall, M., Kasper, C. E., Weathers, R. E., Whitton, J. A., Green, D. M., Donaldson, S. S., Mertens, A. C., Robison, L. L. and Boice, J. D. Jr. (2006). Female survivors of childhood cancer: preterm birth and low birth weight among their children. Journal of the National Cancer Institute, 98, 14531461.
  • Silverman, K. A., Koratkar, R., Siracusa, L. D. and Buchberg, A. M. (2002). Identification of the modifier of Min 2 (Mom2) Locus, a new mutation that influences Apc-induced intestinal neoplasia. Genome Research, 12, 8897.
  • Singer, T. M., Lambert, I. B., Williams, A., Douglas, G. R. and Yauk, C. L. (2006). Detection of induced male germline mutation: correlations and comparisons between traditional germline mutation assays, transgenic rodent assays and expanded simple tandem repeat instability assays. Mutation Research, 598, 164193.
  • Singh, N. P., McCoy, M. T., Tice, R. R. and Schneider, E. L. (1998). A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research, 175, 184191.
  • Smith, A. J. O., Almeida, G. M., Thomas, A. L. and Jones, G. D. (2007). Comet assay measures of irinotecan-induced DNA damage in vitro and in vivo. Proceedings of the Genome Stability Network/United Kingdom Environmental Mutagen Society Joint Congress, University of Cardiff, 1–4 July 2007.
  • Smith, C. C., Archer, G. E., Forster, E. J., Lambert, T. R., Rees, R. W. and Lynch, A. M. (1999). Analysis of gene mutations and clastogenicity following short-term treatment with azathioprine in MutaMouse. Environmental and Molecular Mutagenesis, 34, 131139.
  • Smith, D. F., MacGregor, J. T., Hiatt, R. A., Hooper, N. K., Wehr, C. M., Peters, B., Goldman, L. R., Yuan, L. A., Smith, P. A. and Becker, C. E. (1990). Micronucleated erythrocytes as an index of cytogenetic damage in humans: demographic and dietary factors associated with micronucleated erythrocytes in splenectomized subjects. Cancer Research, 50, 50495054.
  • Smits, R., Kartheuser, A., Jagmohan-Changur, S., Leblanc, V., Breukel, C., de Vries, A., van Kranen, H., van Krieken, J. H., Williamson, S., Edelmann, W., Kucherlapati, R., Khan, P. M. and Fodde, R. (1997). Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638 N, a mouse model for Apc-driven carcinogenesis. Carcinogenesis, 18, 321327.
  • Snyder, R. D. (2007). Assessment of atypical DNA intercalating agents in biological and in silico systems. Mutation Research, 623, 7282.
  • Soejima, H., Zhao, W. and Mukai, T. (2005). Epigenetic silencing of the MGMT gene in cancer. Biochemistry and Cell Biology, 4, 429437.
  • Sonoda, E., Hochegger, H., Saberi, A., Taniguchi, Y. and Takeda, S. (2006). Differential usage of non-homologous end-joining and homologous recombination in double strand break repair. DNA Repair, 5, 10211029.
  • Soravia, C., Berk, T., Madlensky, L., Mitri, A., Cheng, H., Gallinger, S., Cohen, Z. and Bapat, B. (1998). Genotype-phenotype correlations in attenuated adenomatous polyposis coli. American Journal of Human Genetics, 62, 12901301.
  • Stewart, T. A., Pattengale, P. K. and Leder, P. (1984). Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell, 38, 627637.
  • Stopper, H., Hempel, K., Reiners, C., Vershenya, S., Lorenz, R., Vukicevic, V., Heidland, A. and Grawe, J. (2005). Pilot study for comparison of reticulocyte-micronuclei with lymphocyte-micronuclei in human biomonitoring. Toxicology Letters, 156, 351360.
  • Su, L. K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A. and Dove, W. F. (1992). Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science, 256, 668670.
  • Su, H. and Lau, Y. F. C. (1993). Identification of the transcriptional unit, structural organization, and promoter sequence of the human sex-determining region Y (SRY) gene, using a reverse genetic approach. American Journal of Human Genetics, 52, 2438.
  • Suehiro, Y. and Hinoda, Y. (2008). Genetic and epigenetic changes in aberrant crypt foci and serrated polyps. Cancer Science, 99, 10711076.
  • Sugo, N., Aratani, Y., Nagashima, Y., Kubota, Y. and Koyama, H. (2000). Neonatal lethality with abnormal neurogenesis in mice deficient in DNA polymerase beta. The EMBO Journal, 19, 13971404.
  • Suzuki, T., Hayashi, M., Sofuni, T. and Myhr, B. C. (1993). The concomitant detection of gene mutation and micronucleus induction by mitomycin C in vivo using lacZ transgenic mice. Mutation Research, 285, 219224.
  • Suzuki, T., Hayashi, M., Wang, X., Yamamoto, K., Ono, T., Myhr, B. and Sofuni, T. (1997). A comparison of the genotoxicity of ethylnitrosourea and ethyl methanesulfonate in lacZ transgenic mice (Muta Mouse). Mutation Research, 395, 7582.
  • Swiger, R. R., Myhr, B. and Tucker, J. D. (1994). The LacZ transgene in MutaMouse maps to chromosome 3. Mutation Research, 325, 145148.
  • Tan, T. L., Essers, J., Citterio, E., Swagemakers, S. M., de Wit, J., Benson, F. E., Hoeijmakers, J. H. and Kanaar, R. (1999). Mouse Rad54 affects DNA conformation and DNA-damage-induced Rad51 foci formation. Current Biology, 9, 325328.
  • Tebbs, R. S., Flannery, M. L., Meneses, J. J., Hartmann, A., Tucker, J. D., Thompson, L. H., Cleaver, J. E. and Pedersen, R. A. (1999). Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. Developmental Biology, 208, 513529.
  • Thomas, M. C. and Chiang, C. M. (2006). The general transcription machinery and general cofactors. Critical Reviews in Biochemistry and Molecular Biology, 3, 105178.
  • Thoms, K. M., Kuschal, C. and Emmert, S. (2007). Lessons learned from DNA repair defective syndromes. Experimental Dermatology, 16, 532544.
  • Threshold of Regulation for Substances Used in Food-Contact Articles (Final Rule), 60, 36582–36596 (1995). US Food and Drug Administration (FDA), Federal Register.
  • Thybaud, V., Aardema, M., Casciano, D., Dellarco, V., Embry, M. R., Gollapudi, B. B., Hayashi, M., Holsapple, M. P., Jacobson-Kram, D., Kasper, P., Macgregor, J. T. and Rees, R. (2007b). Relevance and follow-up of positive results in in vitro genetic toxicity assays: an ILSI-HESI initiative. Mutation Research, 633, 6779.
  • Thybaud, V., Aardema, M., Clements, J., Dearfield, K., Galloway, S., Hayashi, M., Jacobson-Kram, D., Kirkland, D., MacGregor, J. T., Marzin, D., Ohyama, W., Schuler, M., Suzuki, H. and Zeiger, E. (2007a). Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing. Mutation Research, 627, 4158.
  • Thybaud, V., Dean, S., Nohmi, T., de Boer, J., Douglas, G. R., Glickman, B. W., Gorelick, N. J., Heddle, J. A., Heflich, R. H., Lambert, I., Martus, H. J., Mirsalis, J. C., Suzuki, T. and Yajima, N. (2003). In vivo transgenic mutation assays. Mutation Research, 540, 141151.
  • Tice, R. R., Agurell, E., Anderson, D., Burlinson, B., Hartmann, A., Kobayashi, H., Miyamae, Y., Rojas, E., Ryu, J.-C. and Sasaki, Y. F. (2000). Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environmental and Molecular Mutagenesis, 35, 206221.
  • Tischfield, J. A. and Shao, C. (2003). Somatic recombination redux. Nature Genetics, 33, 56.
  • Todd, J. A. (1999). From genome to aetiology in a multifactorial disease, type 1 diabetes. BioEssays, 21, 164174.
  • Todd, M. D., Lee, M. J., Williams, J. L., Nalezny, J. M., Gee, P., Benjamin, M. B. and Farr, S. B. (1995). The CAT-Tox (L) assay: a sensitive and specific measure of stress-induced transcription in transformed human liver cells. Fundamental and Applied Toxicology, 28, 118128.
  • Torous, D. K., Dertinger, S. D., Hall, N. E. and Tometsko, C. R. (2000). Enumeration of micronucleated reticulocytes in rat peripheral blood: a flow cytometric study. Mutation Research, 465, 9199.
  • Torous, D. K., Hall, N. E., Murante, F. G., Gleason, S. E., Tometsko, C. R. and Dertinger, S. D. (2003). Comparative scoring of micronucleated reticulocytes in rat peripheral blood by flow cytometry and microscopy. Toxicological Sciences, 74, 309314.
  • Torous, D. K., Hall, N. E., Illi-Love, A. H., Diehl, M. S., Cederbrant, K., Sandelin, K., Ponten, I., Bolcsfoldi, G., Ferguson, L. R., Pearson, A., Majeska, J. B., Tarca, J. P., Hynes, G. M., Lynch, A. M., McNamee, J. P., Bellier, P. V., Parenteau, M., Blakey, D., Bayley, J., van der Leede, B. J., Vanparys, P., Harbach, P. R., Zhao, S., Filipunas, A. L., Johnson, C. W., Tometsko, C. R. and Dertinger, S. D. (2005). Interlaboratory validation of a CD71-based flow cytometric method (Microflow®) for the scoring of micronucleated reticulocytes in mouse peripheral blood. Environmental and Molecular Mutagenesis, 45, 4455.
  • Toyooka, K. O., Toyooka, S., Virmani, A. K., Sathyanarayana, U. G., Euhus, D. M., Gilcrease, M., Minna, J. D. and Gazdar, A. F. (2001). Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Research, 11, 45564560.
  • Truglio, J. J., Croteau, D. L., Van Houten, B. and Kisker, C. (2006). Prokaryotic nucleotide excision repair: the UvrABC system. Chemical Reviews, 106, 233252.
  • Tucker, J. D., Vanderlaan, M., Kwan, T. C., Moore D. H. II and Felton, J. S. (1993). Effects of diet and folate on levels of micronucleated polychromatic erythrocytes. Mutation Research, 301, 1926.
  • Turnpenny, P. and Ellard, S. (2005). Emery's Elements of Medical Genetics, 12th edn. Elsevier Churchill Livingston, Edinburgh.
  • Tweats, D. J., Blakey, D., Heflich, R. H., Jacobs, A., Jacobsen, S. D., Morita, T., Nohmi, T., O'Donovan, M. R., Sasaki, Y. F., Sofuni, T. and Tice, R. (2007). Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards. Mutation Research, 627, 7891.
  • Tweats, D. J. and Gatehouse, D. D. (1999). Mutagenicity. In Ballantyne, B., Marrs, T. C. and Syversen, T. (Eds), General and Applied Toxicology, 2nd edn. McMillan Press, London, pp. 10161079.
  • Ubeda, F. and Wilkins, J. F. (2008). Imprinted genes and human disease: an evolutionary perspective. Advances in Experimental Medicine and Biology, 626, 101115.
  • US Environmental Protection Agency (EPA) (2005a). Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001F, March 2005. US EPA, Washington, DC. www.epa.gov/cancerguidelines
  • US Environmental Protection Agency (EPA) (2005b). Supplemental Guidance for Assessing Cancer Susceptibility from Early-life Exposure to Carcinogens. EPA/630/R-03/003F, March 2005. US EPA, Washington, DC.
  • Valerie, K. and Povirk, L. F. (2003). Regulation and mechanisms of mammalian doublestrand break repair. Oncogene, 22, 57925812.
  • Vanasse, G. J., Concannon, P. and Willerford, D. M. (1999). Regulated genomic instability and neoplasia in the lymphoid lineage. Blood, 94, 39974010.
  • Van Gompel, J., Woestenborghs, F., Beerens, D., Mackie, C., Cahill, P. A., Knight, A. W., Billinton, N., Tweats, D. J. and Walmsley, R. M. (2005). An assessment of the utility of the yeast GreenScreen assay in pharmaceutical screening. Mutagenesis, 20, 449454.
  • Vijg, J. (2000). Somatic mutations and aging: a re-evaluation. Mutation Research, 447, 117135.
  • Vitolo, J. M., Thiriet, C. and Hayes, J. J. (2000). The H3-H4 N-terminal tail domains are the primary mediators of transcription factor IIIA access to 5 S DNA within a nucleosome. Molecular and Cellular Biology, 6, 21672175.
  • de Vries, H. (1900). Sur la loi de disjonction des hybrides. Comptes Rendus de l'Académie des Sciences (Paris), 130, 845847.
  • de Vries, A., Dolle, M. E., Broekhof, J. L., Muller, J. J., Kroese, E. D., van Kreijl, C. F., Capel, P. J., Vijg, J. and van Steeg, H. (1997). Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/lacZ transgenic mice after oral treatment with benzo[a]pyrene: correlation with tumour development. Carcinogenesis, 18, 23272332.
  • Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M. and Bos, J. L. (1988). Genetic alterations during colorectal-tumor development. The New England Journal of Medicine, 319, 525532.
  • Wakata, A., Matsuoka, A., Yamakage, K., Yoshida, J., Kubo, K., Kobayashi, K., Senjyu, N., Itoh, S., Miyajima, H., Hamada, S., Nishida, S., Araki, H., Yamamura, E., Matsui, A., Thybaud, V., Lorenzon, G., Marzin, D. and Lorge, E. (2006). SFTG International collaborative study on the in vitro micronucleus test. IV. Using CHO/IU cells. Mutation Research, 607, 88124.
  • Walmsley, R. M. (2005). Genotoxicity screening: the slow march to the future. Expert Opinion on Drug Metabolism and Toxicology, 1, 261268.
  • Walmsley, R. M., Billinton, N. and Heyer, W. D. (1997). Green fluorescent protein as a reporter for the DNA damage-induced gene RAD54 from Saccharomyces cerevisiae. Yeast, 13, 15351545.
  • Wassom, J. S. (1989). Origins of genetic toxicology and the environmental mutagen society. Environmental and Molecular Mutagenesis, 14 (Suppl 16), 16.
  • Watanabe, M., Ishidate, M. and Nohmi, T. (1990). Sensitive method for the detection of mutagenic nitroarenes and aromatic amines: new derivatives of Salmonella typhimurium tester strains possessing elevated O-acetyltransferase levels. Mutation Research, 234, 337348.
  • Watson, J. and Crick, F. H. (1953). Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature, 171, 737738.
  • de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R. and Subramani, S. (1987). Firefly luciferase gene: structure and expression in mammalian cells. Molecular and Cellular Biology, 7, 725737.
  • Wilcox, P., Naidoo, A., Wedd, D. J. and Gatehouse, D. G. (1990). Comparison of Salmonella typhimurium TA102 with Escherichia coli WP2 tester strains. Mutagenesis, 5, 285291.
  • Wild, C. P. and Pisani, P. (1998). Carcinogen DNA and protein adducts as biomarkers of human exposure in environmental cancer epidemiology. Cancer Detection and Prevention, 22, 273283.
  • Williams, G. M. (1976). Carcinogen-induced DNA repair in primary rat liver cell cultures; a possible screen for chemical carcinogens. Cancer Letters, 1, 231236.
  • Williams, G. M. (1977). Detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell cultures. Cancer Research, 37, 18451851.
  • Wilson, D. M. III and Bohr, V. A. (2007). The mechanics of base excision repair, and its relationship to aging and disease. DNA Repair, 6, 544559.
  • Witt, K. L., Cunningham, C. K., Patterson, K. B., Kissling, G. E., Dertinger, S. D. and Bishop J. B. (2007). Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV. Environmental and Molecular Mutagenesis, 48, 322329.
  • Wood, R. D., Mitchell, M. and Lindahl, T. (2005). Human DNA repair genes. Mutation Research, 577, 275283.
  • Wurgler, F. E., Sobels, F. H. and Vogel, E. (1984). Drosophila as assay system for detecting genetic changes. In Kilbey, B. J., Legator, M., Nichols, W. and Ramel, C. (Eds), Handbook of Mutagenicity Test Procedures, 2nd edn. Elsevier, Amsterdam, pp. 555601.
  • Xie, Y., Yang, H., Cunanan, C., Okamoto, K., Shibata, D., Pan, J., Barnes, D. E., Lindahl, T., McIlhatton, M., Fishel, R. and Miller, J. H. (2004). Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. Cancer Research, 64, 30963102.
  • Yahagi, T., Degawa, M., Seino, Y., Matsushima, T., Nagao, M., Sugimura, T. and Hashimoto, Y. (1975). Mutagenicity of carcinogen azo dyes and their derivatives. Cancer Letters, 1, 9196.
  • Yamada, M., Sedgwick, B., Sofuni, T. and Nohmi, T. (1995). Construction and characterization of mutants of S typhimurium deficient in DNA repair of 06-methylguanine. Journal of Bacteriology, 177, 15111519.
  • Yamamoto, S., Hayashi, Y., Mitsumori, K. and Nomura, T. (1997). Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene. Laboratory Animals, 47, 121126.
  • Yanofsky, C. (1971). Mutagenesis studies with Escherichia coli mutants with known amino acids (and basepair) changes. In Hollaender, A. (Ed.), Chemical Mutagens, Principles and Methods for their Detection, Vol. 1, Plenum Press, New York, pp. 283287.
  • Yang, K., Edelmann, W., Fan, K., Lau, K., Kolli, V. R., Fodde, R., Khan, P. M., Kucherlapati, R. and Lipkin, M. (1997). A mouse model of human familial adenomatous polyposis. The Journal of Experimental Zoology, 277, 245254.
  • Yap, K. L. and Zhou, M. M. (2006). Structure and function of protein modules in chromatin biology. Results and Problems in Cell Differentiation, 41, 123.
  • Yin, Y. and Shen, W. H. (2008). PTEN: a new guardian of the genome. Oncogene, 27, 54435453.
  • Yoon, T., Chakrabortty, A., Franks, R., Valli, T., Kiyokawa, H. and Raychaudhuri, P. (2005). Tumor-prone phenotype of the DDB2- deficient mice. Oncogene, 24, 469478.
  • Zeiger, E. (1985). The Salmonella mutagenicity assay for identification of presumptive carcinogens. In Milman, H. A. and Weisburger, E. K. (Eds), Handbook of Carcinogen Testing. Noyes Publishers, Park Ridge, pp. 8399.
  • Zeiger, E. (1987). Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity. Cancer Research, 47, 12871296.
  • Zhan, Q. (2005). Gadd45a, a p53- and BRCA1-regulated stress protein, in cellular response to DNA damage. Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, 569, 133143.
  • Zhang, H. S. and Dean, D. C. (2001). Rb-mediated chromatin structure regulation and transcriptional repression. Oncogene, 24, 31343138.
  • Zheng, L., Pan, H., Li, S., Flesken-Nikition, A., Chen, P. L., Boyer, T. G. and Lee, W. H. (2000). Sequence specific transcriptional co-repressor function for BRCA1 through a novel zinc finger protein, ZBRK1. Molecular Cell, 6, 757768.
  • Zúñiga, G., Torres-Bugaŕin, O., Ramírez-Muñoz, M. P., Delgado-Lamas, J. L., De Loza-Saldaña, R. and Cantú, J. M. (1996). Micronucleated erythrocytes in splenectomized patients with and without chemotherapy. Mutation Research, 361, 107112.

Further Reading

  1. References
  2. Further Reading
  • Committee for Proprietary Medicinal Products (CPMP) (2002). Notes for Guidance on Photosafety Testing. CPMP/SWP/398/01. London, 27 June 2002.
  • ICH (2002). ICH Harmonised Tripartite Guideline Impurities: Guideline for Residual Solvents Q3 C. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Secretariat, Geneva.
  • ICH (2003). ICH Harmonised Tripartite Guideline Impurities: Impurities in New Drug Substances Q3A(R). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Secretariat, Geneva.
  • ICH (2006). ICH Harmonised Tripartite Guideline Impurities: Impurities in New Drug Products Q3B(R). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Secretariat, Geneva.
  • ICH (2008). S2(R1): Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Secretariat, Geneva.